RCM & Prior Auth AI

Surescripts is the network almost every other vendor in this lane routes across, and it should be read directly against the DrFirst record built alongside it. Both companies attack the same problem, the unstructured sig instruction, and they attack it from opposite positions: DrFirst as a participant enhancing data after it arrives, Surescripts as the network enhancing it in transit. The scale is the defining fact. Healthcare professionals exchanged 30.5 billion transactions through the Surescripts Network Alliance in 2025. The company connects electronic health record vendors, pharmacies, pharmacy benefit managers, health plans, health systems, long term and post acute care, specialty pharmacies, life sciences companies and analytics vendors, and its product set runs from electronic prescribing and controlled substance prescribing through medication history, eligibility, formulary, real time prescription benefit, electronic prior authorisation and prescription transfer. Sig IQ is the machine learning product and it does the same job as DrFirst's SmartSig. It translates free text patient directions into the Structured and Codified Sig format, a standardised structure that removes ambiguity, and the company describes it as catching confusing or potentially dangerous sigs before they reach patients. Two design details distinguish it. It is anchored to the NCPDP industry standard rather than a proprietary schema, and the company states it uses a pharmacist review process alongside the model. Introduced for medication history in 2022 and extended to prescribing transactions in late 2023, it delivered 4.1 billion structured sigs in 2024 against 1.9 billion the year before, and augmented more than two million renewal transactions in its first six months on that pathway. Artificial intelligence appears elsewhere in the network and the company enumerates where, which is unusual. A semantic network underpins the workflow engine in the electronic prior authorisation portal. Record Locator and Exchange and the Specialty Medications Gateway use models to break down clinical document architectures and identify unique clinical attributes. And the company discloses a development detail most vendors would omit: it used artificial intelligence to parse text sigs, and that work informed the machine learning techniques built into Sig IQ. In August 2024 it published a formal artificial intelligence commitment under four named principles, ethical use, privacy and security, transparency, and accountability, with the ethical use principle explicitly naming potential biases and the accountability principle committing to prioritise appropriate human oversight. A named chief data and analytics officer, a physician, publishes on keeping humans in the loop. Formed in 2008 through the merger of SureScripts and RxHub, both founded in 2001 by pharmacy and pharmacy benefit trade organisations respectively. Based in Arlington, Virginia, led by chief executive Frank Harvey, and publishing an annual impact report.

DrFirst fills the gap this lane had. The seventeen records already here are clinical decision support and pharmacokinetics: interaction checking, dosing models, adherence prediction. All of them assume the medication data arriving in the chart is usable. DrFirst works on the assumption itself, and its central claim is that the assumption is false. The problem is the sig, the shorthand prescribing instruction carrying dose, route and timing. When medication history is imported into an electronic health record it arrives as unstructured free text, frequently incomplete, and written in whatever synonym the source system used, by mouth against orally against PO. The company states that an estimated 66 percent of records in the largest national medication history database are missing essential sig information. Data in that condition cannot trigger the interaction and allergy checks the record system is capable of running, so the safety machinery every other vendor in this lane depends on is silently disarmed. SmartSig is the patented artificial intelligence that addresses it, converting free text into discrete sig components, codifying them into each facility's standard terminology, and supplying alternative drug identifiers for best case matching where a medication cannot be resolved. It sits inside MedHx, the medication history product, and both now sit inside Fuzion, an enterprise platform launched in 2023 that the company describes as running on clinical grade artificial intelligence. The deployment evidence is the strongest thing on this record and several institutions publish it themselves. Hackensack Meridian Health reports that automatic sig mapping rose from 26 percent to 86 percent across a sample of 300,000 medications. Scripps reports medication history available for 96 percent of patients over 65 with 85 percent of home medication sigs enhanced. Monument Health reports 93 and 82 percent on the same measures. Covenant HealthCare reported recapturing 15 percent productivity per shift in the first month, which it valued at roughly $650,000 a month. Emory Healthcare reports a 13 percent improvement in best possible medication history. Around the medication history work sits a much larger business: electronic prescribing through Rcopia and iPrescribe, controlled substance prescribing, secure clinical messaging through Backline, benefits checking and adherence. The 2024 acquisition of Myndshft extended prior authorisation from pharmacy benefit into medical benefit, covering eligibility for 95 percent of insured patients and authorisation requirements for more than 600 payers. Founded in 2000 by James F. Chen and based in Rockville, Maryland, with recent announcements datelined Arlington, Virginia. Roughly 459 employees and $135M raised across eight rounds. G. Cameron Deemer joined in 2004 and led the company as chief executive for two decades, and sources disagree on whether he still holds the role following a July 2025 announcement referring to him continuing as vice chairman of the board.

Yosi Health is Clearwave's opposite number and the pair are worth reading together. Both automate the front desk for specialty and ambulatory practices. Clearwave grew from a waiting room kiosk and still deploys hardware; Yosi was built pre arrival and mobile first, on the premise that the registration should be finished before the patient walks in. The company claims to have been the first remote pre arrival patient intake software. The product covers self scheduling from a practice website, pre arrival digital intake, automatic check in, real time eligibility and benefits checks, pre and post visit payment collection, two way texting, surveys and reputation management, and telehealth. Check in runs through tablet kiosks, quick response codes or location detection on the patient's phone, without front desk intervention. The company reports 84 to 85 percent of patients fully pre registering before arrival. Two design decisions distinguish it from competitors and both address the same practical objection. Practices are not required to change their existing forms: the platform maps patient answers onto whatever forms a practice already uses, delivers discrete data into the record system and also produces a completed, signed and dated document packet. And intake questionnaires carry autoscoring, configured by appointment type, patient category, provider and specialty, so a screener produces a score rather than free text a clinician must read and total. The artificial intelligence is narrow and is the basis for enrolment. Voice automation handles routine scheduling and, in the company's own description, triage, providing an always on layer that reduces hold times and routes urgent calls appropriately without replacing the human touch. That is a modest claim, honestly bounded, and it is the strongest model claim on the record. Intake autofill and form mapping are the other candidates and are more plausibly deterministic. The security posture is the most complete of any small vendor assessed in this session and stands in direct contrast to Clearwave, which publishes none. Yosi states service organisation control type 1 and type 2 certification, HITRUST common security framework certification, payment card industry compliance, status as an advanced technology partner in a major cloud provider's independent software vendor programme, and a documented 99.95 percent uptime figure. For a company of this size holding all four credentials is a deliberate and expensive choice. Founded in 2014 in New York by Hari Prasad, after an experience being handed a clipboard at an urgent care with a dislocated shoulder, with the founding team described as physicians and healthcare professionals. Seed funded, with Dreamit named as an investor. Record system integrations are named across Epic, Oracle Health, Allscripts, athenahealth, AdvancedMD and Elation, with real time two way data transfer described, and the platform joined the ModMed specialty marketplace in October 2025. Two things a reader should weigh. The company is small and seed stage against competitors that have raised tens or hundreds of millions, so buyers should weigh continuity accordingly. And the operational figures throughout, including pre registration rates and uptime, are self reported with no method stated.

Clearwave occupies the point in the patient journey nobody else in this index owns end to end: the front desk. Scheduling, eligibility verification, pre registration, check in, clinical intake and payment collection, sold predominantly to specialty practices and multi site groups rather than to academic health systems. The company began as a check in kiosk roughly a decade ago and the physical heritage still shows in how the product is deployed, across kiosks, tablets, mobile devices and pre visit links, with passwordless patient led registration. That kiosk lineage is the reason the operational figures are unusually specific and unusually good: 99 percent patient adoption of registration, check in times down 90 percent, collection rates of 96 percent during check in, point of service collections up between 85 and 154 percent, and eligibility checks running across more than 900 payers. Those numbers come from a product that has been iterated against real waiting rooms for years rather than from a recent launch. On 12 August 2026 the company repositioned the whole platform around what it calls an agentic workforce, naming eight agents: voice answering inbound calls and booking, confirming, cancelling and rescheduling; scheduling filling the calendar across phone, online, search and call centre; eligibility running real time checks; clinical intake collecting clinical data before arrival; pre registration capturing demographics and consents; check in completing in under two minutes; payments collecting copay, past due balances and surcharges; and communications. The stated volumes are substantial, with the voice agent handling more than 50,000 patient calls a month at roughly 90 seconds each, and the check in and pre registration agents described as automating 150 million patient visits a year. The positioning claim is worth quoting in substance because it is the argument the whole record turns on. The company frames the platform as automating the work rather than as software that helps staff work faster, and pitches one platform replacing as many as ten point solutions. That is a strong claim about autonomy and it is made two weeks before this assessment, which matters for how much weight the evidence can carry. Based in Atlanta, Georgia. Practice management and record system integrations are described as deep, with NextGen named specifically and the integration marketed jointly. Two things a reader should weigh. The registration and eligibility evidence is mature and specific; the agentic evidence is a launch announcement carrying figures of 63 percent faster than human agents, an 89 percent drop in staff workloads and 86 percent less training time, none of which has a stated method, baseline or comparison group. And the product sits at the intersection of clinical intake and payment collection, which means the same interface that asks a patient about their symptoms also asks them for money, and nothing published addresses how those two functions are kept separate in the patient's experience.

Inovalon is a data business that sells analytics, and the data asset is the reason it matters. The MORE2 Registry, its Medical Outcomes Research for Effectiveness and Economics dataset, is described as drawing on more than 160 primary sources across all fifty states and holding upwards of 99 billion medical, pharmacy and laboratory events covering 1.1 million clinicians and hundreds of millions of unique lives. The company is also a Qualified Entity under the Centers for Medicare and Medicaid Services programme of that name, which permits access to complete Medicare fee for service data for defined purposes. Very few organisations hold a comparable position, and everything else the company sells rests on it. Inovalon ONE is the platform layer, combining national scale connectivity to electronic health record systems and health information exchanges with real time primary source data and analytics, and it carries more than 100 software solutions reached through a single sign on portal. Four buyer markets are served from it. Payer products centre on Converged Quality, which supports quality measurement, reporting and improvement across HEDIS, Medicare star ratings and state programmes. Provider products, built on the acquired ABILITY Network and now the Provider Cloud, cover revenue cycle, care quality and workforce management. Pharmacy products serve specialty and infusion operations. Life sciences products license data and analytics for research, health economics and trial work. This record grades the company as one entity because a single platform, a single data asset and a single compliance posture underlie all four lines. Two ownership points sit alongside it. VigiLanz, acquired in February 2024 and graded separately in this index, is still sold under its own name and its record documents the ownership. And Inovalon was taken private in August 2021 at an enterprise value of roughly 7.3 billion dollars by a consortium led by Nordic Capital with Insight Partners, 22C Capital and founder and chief executive Keith Dunleavy. The external validation record is the strongest in this lane. Converged Quality earned its twenty sixth consecutive National Committee for Quality Assurance measure certification in July 2026 together with validation of its digital quality measure engine, and took the 2026 category award for quality measurement and reporting analytics in a research firm's customer survey. The company states more than 100 health plans use the product, representing a majority of enrolment in four star and above Medicare Advantage plans, alongside more than 50,000 licensed customers overall. Headquartered in Bowie, Maryland. Two things a reader should weigh. Data gathered while serving payers and providers also supports a licensing business selling data and analytics to pharmaceutical and life sciences customers, and no published statement explains what permissions govern that second use. And no pricing of any kind was located.

Astrata reads clinical charts so quality teams do not have to. The company builds natural language processing for healthcare quality measurement, aimed squarely at the HEDIS reporting that determines health plan star ratings and quality bonus payments. Chart Review performs assisted abstraction for prospective, year round HEDIS work rather than the annual scramble. A separate text platform exposes the same unstructured data capability for risk adjustment and other chart based activities. eMeasure is a measure engine built natively on FHIR and CQL. Quality Navigator applies the same analysis to targeting member and patient outreach. The technology has an unusually documented lineage. The company describes a platform developed over almost two decades with National Institutes of Health funding, combining multiple natural language processing, machine learning and artificial intelligence techniques. It was spun out of UPMC Enterprises as an independent company, with the first product built alongside UPMC Health Plan to underpin that plan's own prospective HEDIS programme, so the initial customer was also the co developer. Credentials in this domain are held rather than claimed. eMeasure was among the first digital HEDIS engines to earn National Committee for Quality Assurance certification for new digital measures, initially covering breast and colorectal cancer screening, achieved with a FHIR data platform partner. The company states it is the only recipient of the accrediting body's data partner certification for natural language processing assisted clinical document enrichment, and one of only three companies invited into that body's natural language processing working group. Separately it holds HITRUST r2 certification, the highest assurance tier of the health specific security framework. The disclosure practice around accuracy deserves particular attention because it is rare. The company states that it measures natural language processing performance at every stage from measure development through tuning to performance in production, and that it supplies customers with the reports and tooling to see that accuracy directly and to satisfy their own auditors. It reports that customers have had a complete success rate with accrediting body auditors, which is the operational test that matters in this field, since a quality submission that cannot survive audit is worthless. Based in Pittsburgh and led by chief executive Rebecca Jacobson. Buyers are health plans and accountable care organisations. The company also publishes a page setting out what it is and is not, which is a deliberate scoping exercise few vendors attempt. No pricing of any kind was located, and no public accuracy figures are published, though customers receive them.

Luminai automates the administrative work health systems still do by hand, end to end rather than task by task. Healthcare trained models structure unstructured documents and fragmented data, workflow automation carries the resulting actions across disconnected systems, and human in the loop validation gates the steps that need a person. Named workflows span referral intake, provider inbox automation, patient registration, order and referral processing, pharmacy renewals, payor contract management, denial appeals and underpayment recovery, grouped commercially under patient access, revenue cycle and compliance. The integration approach is the unusual part and comes from the company's earlier life as a cross industry automation platform. Rather than requiring an interface build, the software operates the systems a team already uses, which means it can reach applications that expose no usable programming interface. That is how the platform gets into the corners of health system operations where the data lives in a portal nobody can integrate with, and it is also why standards based interoperability is not the story here. The security and deployment posture is the strongest element of the record and is unusual for a company at this stage. Three deployment models are offered: on premise, inside the customer's own virtual private cloud, or vendor managed. Alongside that the company describes encrypted data, isolated execution and, notably, customer owned credentials, meaning the automation acts using the customer's own system credentials rather than the vendor holding them. Alignment is claimed against United States health privacy law, service organisation controls and European data protection law. A 38 million dollar Series B closed in April 2026, led by Peak XV Partners with new investor Define Ventures and continued backing from General Catalyst and Y Combinator, bringing total capital to 60 million. The team draws from Palantir, Google, Coinbase and Brex on the technology side and from Epic and Banner Health on the operator side. Based in San Francisco. Two cautions. The company states it is trusted by large health systems and names none of them publicly, so no customer, deployment scale or outcome could be verified. And several third party directory pages carry precise sounding figures for return on investment and time to value that trace to no primary source and bear the marks of generated content; none of them informed this record.

Aidin runs the discharge referral, from the moment a case manager decides a patient needs post acute care to the moment a facility accepts them. Referrals, records, authorizations and care partner relationships sit in one platform, and the document layer absorbs the formats this work still arrives in, pulling material from fax, email and the company's own print path and classifying it against the right patient and request. Task flags surface incomplete flows, at risk cases and overdue assignments, and a secure messaging layer replaces the phone calls. The distinctive design choice is the open market. Rather than routing patients to a hospital's existing preferred partners, Aidin presents post acute providers with objective quality, satisfaction and outcome data so the patient can choose, and it operates a national directory of care partners on the other side. Post acute providers get free access to receive referrals, with paid tiers named as Verified, Community and Enterprise unlocking record system integration, custom reporting and team workflow. That two sided structure means the platform's reach on the receiving side is a commercial asset in its own right. Customers named in company case material include UCLA Health, five hospitals of the Ohio State University Medical Center, St. Luke's, Elmhurst Edward Hospital and Western Maryland Health System, with stated objectives around average length of stay, inpatient bed capacity and readmission reduction. Regulatory posture is more directly addressed than in most records here. The platform is built against the federal post acute discharge list requirements, which oblige hospitals to give patients quality data and a genuine choice of provider, and the open market model is a direct implementation of that obligation rather than a feature bolted beside it. Led by chief executive Russ Graney. One thing a reader should hold. The company describes an artificial intelligence powered platform, and the identifiable machine learning in it is document intake classification and provider quality analytics. Around that sits a directory, a workflow tool, an authorization tracker and a messaging layer, none of which is inference. No model is described, no performance figure is published for any component, and a dedicated pass located no security page, no external attestation and no published price. This record grades the disclosure available rather than the positioning.

Patient access and revenue cycle automation built around an agent platform the company calls a Healthcare Revenue Operating System. Founded 2012 and headquartered in Cupertino, California, originally as a radiology prior authorisation business, now spanning financial clearance, prior authorisation, document capture, coding, denials and accounts receivable. Backed by KKR and Norwest with roughly 194 million dollars raised, serving a reported 900 or more provider organisations, and having acquired the healthcare revenue cycle business of i3 Verticals. The architecture is a three tier agent model stated plainly. Automation agents handle high volume repetitive work such as eligibility verification, claim status tracking and payment posting. Artificial intelligence agents handle work requiring cognitive reasoning and action, such as classifying and extracting patient detail from referrals or predicting denial risk before submission. Human agent specialists supplied by the company step in for complex denials, payer escalations, credential verification and prior authorisation exceptions. Agent suites sit on top: Patient Access Plus, Document Capture Plus and a revenue cycle suite, available standalone or integrated. Membership was decided on the services filter and survived it. The company's own framing is technology led outcomes delivered through agentic solutions, outsourced operations and consulting, which puts technology rather than expertise in the load bearing position and inverts the Cotiviti formulation. Standalone solutions are offered without a services engagement. And in April 2026 its in scope revenue cycle and patient access platforms and supporting environments attained HITRUST Implemented one year certification under framework version 11.5.1: a certification is scoped to a product and an environment, which is evidence the platform is a discrete licensable thing rather than a wrapper on a service. The company does supply human labour as a named component, which is why the artificial intelligence centrality grade sits below the pure engines in this index. Infrastructure is named more openly than most. Amazon Web Services is the cloud foundation, with a managed foundation model service used for summarisation and workflow understanding, alongside named data stores, private network segmentation, encryption at rest and in transit and permission gated file access. One relationship connects this record to the coding lane. In August 2025 Infinx made a strategic investment in Maverick Medical AI to bring real time autonomous coding into its offering, which means part of the coding capability may originate outside the company. That relationship is documented from the other side in the Maverick record. The gap across this record is measurement. No accuracy figure, automation rate, service commitment or price is published anywhere, and the only quantified customer outcome located is a single named practice reporting case handling time falling from roughly three and a half minutes to under one.

Indexed as a product rather than as a company, under the index by product not company rule. Optum itself is screened out at company level on breadth, following the Hologic precedent; this record covers the qualifying product line only. Optum Integrity One is an autonomous first platform for the middle revenue cycle, launched 7 May 2025 by Optum Insight and powered by the company's patented Clinical Language Intelligence technology. It analyses the patient record as documentation is created, applies coding logic in real time, and completes routine encounters automatically, consolidating clinical documentation review, code assignment and charge capture into one interface. The stated design offers both fully autonomous and partially autonomous coding, escalating to a human expert when clinical signals indicate complexity: the company's worked example has many emergency department cases coded autonomously while a chest pain admission surfaces a documentation opportunity on the likely presence, type and acuity of heart failure, routed to the documentation integrity team for a provider query. Part of the stated value is consolidation rather than intelligence. Published benefits include reduced need for multiple vendors and lower total cost of ownership alongside the automation itself, which distinguishes this from the pure coding engines elsewhere in the lane. Published outcomes are anonymous. A pilot is reported at over 20 percent coding productivity improvement, and one unnamed large health system at 180 percent documentation integrity financial impact with a 50 percent rise in inpatient coding productivity. No accuracy figure, automation rate or named Integrity One customer was located. Named references on the Optum site attach to the older assistive coding products rather than to this platform. Optum was named a leader in a 2026 analyst assessment of revenue cycle platforms, which is a company level ranking. Two structural facts belong on the record because no competitor carries them. The vendor is a subsidiary of the largest health insurer in the United States, so a platform that surfaces documentation opportunities to increase captured clinical acuity is sold to providers by the corporate family that also pays their claims and whose risk adjustment coding practices have drawn federal scrutiny. And Change Healthcare, an Optum company, suffered a ransomware incident in February 2024 subsequently reported as the largest breach of protected health information in United States history. Neither is addressed in the product's published material, and a buyer evaluating protected data handling by an Optum entity will weigh both. Disclosure limitation on this record: a dedicated pass located no security, compliance, integration, residency or pricing material tied to this product. An organisation of this scale certainly maintains extensive compliance infrastructure; none of it was found surfaced at the product level, and company level material was not exhaustively searched. The trust and security axes are graded conservatively for that reason and should be revisited.

Autonomous medical coding and clinical quality abstraction on one engineering stack. The coding product assigns ICD-10, CPT and HCPCS codes across specialties with a source cited justification for every code, scrubs for compliance and can submit directly to the billing system. The quality product abstracts, calculates and submits measures to CMS, The Joint Commission and specialty registries including NCDR, STS and Get With The Guidelines, with MIPS and value pathway submission included. Founded 2023 in Little Rock, Arkansas, with a second office in Seattle. Nathan Myers is president and chief executive; Scott Roper is chief operating officer. The architectural claim is specific and unusual. The company argues that most healthcare artificial intelligence compresses a chart into a summary before the model sees it, because a full inpatient record exceeds standard context windows, and that roughly eighty percent of clinical signal lives in the unstructured prose that summarisation discards. Its stated design processes the entire record including handwriting, and every output cites the passage that supports it. A patent is pending on upstream data structuring. The origin is the fact that shapes this record. AccuCode was founded inside Professional Consulting Services, described as Arkansas's largest third party medical billing firm, and its chief operating officer spent eighteen years there. That relationship matters because the two year accuracy audit the company publicised in August 2026, in which coders certified by the professional coding association measured engine output at above 99 percent accuracy across a large sample, was performed by that same firm, described in the release as a channel partner. It is a related party audit presented as third party verification, and a buyer should treat it as such. The company's own site notably avoids a headline accuracy number, arguing that measurement discipline matters more, and describes validation as hundreds of thousands of records manually confirmed against source documentation and benchmarked against ground truth consensus. Other evidence is genuine. Baptist Health Systems has been a clinical quality abstraction partner since August 2024. A partnership with MedAxiom, the cardiovascular organisation affiliated with the American College of Cardiology, supports the cardiovascular optimisation claim. The trust disclosure is the strongest in this index. The company publishes a publicly linked, daily updated security posture report covering 244 continuously monitored controls, states SOC 2 Type II with scope, commits contractually that customer data is never used to train any foundation model, names its cloud and restricts it to United States regions with no cross border replicas, requires that every person able to access protected health information be based in the United States, and commits to breach notification materially faster than the statutory floor with terms written into every business associate agreement. Scale is the counterweight. The company is unfunded and reported at roughly seven employees, so a buyer is evaluating an exceptional compliance posture attached to a very small operation. Pilots run on one hundred of the buyer's own charts within four weeks, beginning with a signed agreement.

Inpatient medical coding and pre bill auditing software built on custom clinical artificial intelligence and natural language processing. Two products sit on one platform: Semantic Coder reviews charts before they are coded and suggests the relevant diagnosis and procedure codes with a full evidence trail back to the documentation, and Semantic Auditor performs pre bill review of coded data to validate, identify and further specify codes against the clinical record. Founded 2019 in Toronto by Hassan W Bhatti and Nicola Sahar, a physician who serves as president. The positioning is assistive rather than autonomous. The stated aim is to reduce time to code and to let coding and auditing teams focus on high value work, with every suggestion linked directly to the documentation in one interface so that a human can confirm it without consulting other sources. The company draws an explicit contrast with computer assisted coding tools it characterises as rules based or expert curated heuristics, arguing that those produce false positives that cost reviewers more time than they save. One coverage fact distinguishes this record from everything else in the index: the company sells into two national coding regimes, offering American hospitals a pre bill inpatient auditing platform and Canadian hospitals a health information management platform that auto suggests codes and reviews all coded data for quality. No other vendor in this lane addresses a coding system outside the United States. Named customers are Hospital for Sick Children and Humber River Hospital in Toronto, and Boston Children's Hospital and Cedars-Sinai in the United States. Acquired by AAPC on 16 November 2023. AAPC is a Utah based credentialing, education and revenue cycle organisation serving a reported 250,000 members, and its chief business development officer stated at announcement that Semantic Health would remain a separate entity for the foreseeable future with autonomy to operate. The brand passes the distinct presence test: own domain, own product names, own platform identity, and a customer roster that has grown since the close to include two major United States systems not present in 2023 coverage. The caution that matters most on this record is not about the product. The public presence appears to have gone largely static since the acquisition. No security page, pricing information, certification, published performance figure, funding update or product announcement was located in a dedicated pass, and the on site performance statistics render without values. Total disclosed funding is roughly 3.3 million dollars raised before the acquisition. A buyer will have to obtain almost everything through direct contact, and the record should be rechecked before it is a year old.

Clinical artificial intelligence for hospital revenue integrity, built around second level review of every patient chart before final billing. The engine ingests the complete clinical record, reported at more than 30,000 data points per chart with no chart prioritisation, and surfaces missing or incorrect diagnoses, uncaptured charges and denial evidence for the customer's clinical documentation and coding teams to validate. Founded 2020 in New York by Michael Gao, chief executive, and Joshua Geleris, both physicians; Gao previously led artificial intelligence work at NewYork-Presbyterian. The positioning is deliberately not autonomy. The company's stated aim is to empower documentation and coding teams rather than replace them, and every finding is validated by a human before it reaches a claim. That is the opposite pole from Fathom and Nym Health, and it is the reason the record grades the way it does: oversight is total by design and no output is submitted by the vendor. The product line spans the revenue cycle in three stages: SmarterAuthorizations and SmarterUtilization before care, SmarterNotes and SmarterPrebill and SmarterCharges around the encounter, and SmarterDenials and SmarterUnderpayments after the claim. SmarterNotes came out of the September 2025 acquisition of Pieces Technologies and combines note generation with concurrent revenue cycle intelligence. Evidence is the strongest part of the record. Named clients include Novant Health, McLaren Health, UCHealth, OHSU, UAMS, Universal Health Services, Franciscan and Baptist Health Arkansas. Case studies are attributed to named executives at named institutions, including a chief financial officer at McLaren reporting more than 11 million dollars in annualised net new revenue against review of 100 percent of clinical data across 100 percent of charts. The company reports a 5 to 1 return, an average of 2 million dollars in net new annual revenue per 10,000 patient discharges, 100 percent client retention and a KLAS client satisfaction score of 98. Models are stated to be trained on more than 21 million real patient encounters. The central claim carries a structural caveat a buyer should hold onto: net new revenue found is a counterfactual, measuring money the organisation asserts it would otherwise have missed, and no independent audit of that counterfactual exists. Funding is 71 million dollars across three rounds, a seed round in 2022 co led by Flare Capital Partners with Floodgate Fund and Bessemer Venture Partners, and a 50 million dollar Series B in May 2024 led by Transformation Capital. In April 2025 New Mountain Capital invested at a reported one billion dollar valuation, and the business now sits inside that firm's Smarter Technologies platform. The brand passes the distinct presence test comfortably: own domain, own logo, own product line, own application and support subdomains, own current copyright, and no parent branding on the property.

Autonomous medical coding platform that pairs large language models with clinical knowledge graphs, reading unstructured charts in clinical context and assigning specialty specific CPT, ICD-10, HCC and HCPCS codes with modifiers and units, without human intervention. Founded in 2020 by Nitesh Shroff, chief executive, and Preeti Bhargava, chief technology officer, both machine learning doctorates. Headquartered in Austin with engineering in Bengaluru. Company press releases during 2026 carry a San Francisco dateline following the opening of a Bay Area office, so the stated headquarters should be rechecked before this record is quoted. The distribution position is the part worth attention. Arintra has been available through the Epic Toolbox since December 2024 and integrates bidirectionally with Epic, Cerner and Athenahealth, writing claims to billing with no manual retyping. That places it in the same Epic distribution lane as Nym Health rather than alongside vendors that sit beside the record system. Outcome claims are vendor stated: five percent or more revenue uplift, twelve percent or more reduction in accounts receivable days, and forty three percent or more fewer denials. The company reported eight times year over year revenue growth for 2025, thirteen enterprise deals in one hundred days, and monthly coding volume up more than fivefold, now covering most ambulatory specialties along with urgent care, the emergency department, inpatient rounding, radiology and pathology. Independent signal is stronger than most early stage entrants in this category. KLAS published an Emerging Company Spotlight on Arintra in 2026, and the company reports a customer performance score of 93 out of 100 against a stated 2026 Best in KLAS software average of 81.1. It holds HITRUST e1 certification obtained April 2026, a lower tier than the i1 certification Fathom holds. Named customers include Mercyhealth and Med First. In April 2026 it added a documentation improvement capability, extending the product past coding into clinical documentation improvement and payer aware denials insight. Funding is roughly 46 million dollars: 21 million dollars Series A in August 2025 led by Peak XV Partners with Endeavor Health Ventures, Y Combinator, Counterpart Ventures, Spider Capital and Ten13 participating, and approximately 25 million dollars Series B announced 24 August 2026 led by Define Ventures with Yale New Haven Ventures and Endeavor Ventures joining.

Real time autonomous medical coding built on deep learning, sold to providers, payers and revenue cycle management companies rather than to health systems alone. Products are mCoder, the coding engine, and CodePilot, launched November 2024, which surfaces coding intelligence at the point of care rather than after the encounter closes. Headquartered in Tel Aviv. Founding year is unsettled across sources, which give 2017, 2018 and 2019; the company's own about page says 2019 while investor databases cluster on 2018. Founded by Yossi Shahak and Michael Brozino, both former senior McKesson executives. That is an unusual profile in a category dominated by machine learning founders and gives the company an operator rather than researcher orientation. The technical claim rests on proprietary deep learning models plus synthetic data generation, which the company positions as the reason it can reach site specific accuracy without the very large customer chart volumes competitors require for calibration. Stated performance is an 85 percent direct to bill rate at 97 percent accuracy. Direct to bill is the honest metric to compare here, since it measures charts reaching billing untouched rather than accuracy on the subset the engine chose to code. Distribution runs through partnership rather than direct enterprise sales. Maverick completed an implementation at RadNet in December 2024, announced a strategic integration with NewVue.ai and RADPAIR in November 2024, and works with ImagineSoftware. Together these indicate real depth in radiology revenue cycle rather than broad multispecialty coverage, which is why radiology is carried as a secondary category. In August 2025 Infinx made a strategic investment and partnership, which is the relationship most worth watching, since it embeds the engine inside a larger revenue cycle vendor's book of business. Funding is modest at roughly 5.7 million dollars across three rounds from investors including LionBird, Firstime and the Israel Innovation Authority, plus the Infinx corporate investment. Operates in a HIPAA compliant and SOC 2 certified environment. Deployment scale is not publicly disclosed, which is the main gap in this record.

Autonomous medical coding through the XpertCoding product, paired with a business intelligence layer reporting coding accuracy, billing levels and provider performance, with dashboards for fee for service, quality measures and risk adjustment. Founded 2015 in Birmingham, Alabama by two physicians, originally to improve clinical trial access; the first product was XpertTrial, a trials database and patient recruitment platform. Corporate headquarters is now Scottsdale, Arizona with a Birmingham regional office, and company press materials variously give Scottsdale and Phoenix. Led by co founder and chief executive Sameer Ather, a physician with a doctorate, with Mateo Montoya as chief technology officer. The architecture is explicitly hybrid: ensemble machine learning models, neural networks and rules based clinical intelligence together, rather than a single end to end model. Integration is unusually broad at the connection layer, covering API, SMART on FHIR, HL7 ADT messaging and robotic process automation, which suits smaller organizations without modern integration engineering. Published accuracy and turnaround figures do not agree across the company's own materials and should not be quoted without checking the date of the source. Claims located include 95 percent of claims coded within 12 hours at 95 percent accuracy, 98 percent accuracy within 24 hours, and 99 percent accuracy within 24 hours. This is a disclosure quality problem rather than necessarily a performance one, and it is graded as such. Market position is the clearest differentiator in the category. XpertDox targets federally qualified health centers, urgent care, primary care and pediatrics rather than academic medical centers and large integrated delivery networks, and its risk adjustment and quality measure reporting depth fits the value based care arrangements common in that segment. A named FQHC customer is Community Health Programs of the Berkshires, announced November 2025. The company also distributes through billing companies, including a 2024 alliance with Positive Results Billing, and is listed on the athenahealth Marketplace. Funding is small, roughly 2.5 million dollars total, including 1.5 million dollars in 2022 led by the leadership of TN3, an Arizona private equity firm. That capital position, set against enterprise competitors holding tens of millions, is the material risk to record on the supply chain and viability axes.

Autonomous medical coding sold as one member of a named agent lineup rather than as a standalone engine. Amy is the coder; the same platform carries Mark for billing, Adam for accounts receivable, Rachel for appeals and Taylor for analytics. Founded 2022 in San Francisco by Sourabh Agrawal, chief executive, and Shikha Mohanty. Amy reads encounter notes directly from the record system and assigns ICD-10, CPT, HCPCS Level II, evaluation and management levels, modifiers and hierarchical condition categories, with configurable coding grids and payer specific rules. Two design choices distinguish it. Decisions are explainable line by line, with rationale and evidence attached to each assignment, which is the same audit trail argument Nym Health makes. And the platform learns continuously from payer outcomes including denials, reimbursements and underpayments rather than from chart data alone, which is uncommon in this category and carries a governance question the company does not address. Oversight is specified more fully than anywhere else in this lane. A four stage quality process runs model confidence scoring with uncertainty flags, secondary model validation, human review by certified coders, and a live compliance feedback stage tracking claims and corrections in production. The confidence threshold governing when work routes to a human is configurable by the customer rather than fixed by the vendor. Published performance is 97.2 percent coding accuracy, an 85 percent claim automation rate and a 64 percent reduction in overall denials. The company published a parallel coding study across 1,000 emergency department charts comparing its output against expert human coders on the same charts, reporting 97 percent accuracy, turnaround roughly halved and five times more documentation gaps surfaced. That study was designed, run and reported by the vendor. Evidence concentrates in emergency departments and anesthesia. Named customers include Medcor, Homeward, McFarland Clinic, SignatureCare ER and El Mirage ER, alongside anonymised references at a 500 bed hospital, a 400 bed emergency focused hospital and a 150 provider emergency physician group. Integration is claimed across twelve named record and practice management systems, the broadest coverage in the category, though no vendor marketplace listing was located and the company describes custom interfaces built per customer. Data stewardship is the strongest in this lane: customers own their data, it is not sold, shared or repurposed, deletion or export can be requested at any time, and the company states it does not train on customer data without permission, using de identified data or obtained consent. Two cautions for anyone quoting this record. The public material contradicts itself, asserting fully compliant and accurate outputs on the frequently asked questions page against the 97.2 percent figure published elsewhere on the same site, and that page still describes a scribe and a policy reviewer agent that no longer appear in the product navigation. And nothing about pricing is published anywhere. Funding is a single institutional round of undisclosed amount, making this the earliest stage record in the category and the one most likely to need a status recheck within a year.

Autonomous medical coding inside a wider mid revenue cycle platform spanning clinical documentation improvement, coding, pre bill scrubbing, claim submission, accounts receivable follow up and denial appeals. Founded 2023 and headquartered in New York by Dushyant Mishra, chief executive, Jot Sarup Singh, chief technology and product officer, and Abhinay Vyas, chief data officer. Some databases list a Wilmington, Delaware address, which is incorporation rather than operations. The coding engine is RapidCode. RapidAssist is the assisted mode for augmenting existing coders, and RapidRules is a policy engine the company states continuously ingests payer policy updates, denial patterns and regulatory changes. Built on large language models, generating audit ready traceable documentation for the coding team, which is the compliance posture this category has converged on. The differentiating claim is calibration cost. RapidClaims states it customizes pre trained models with roughly 500 sample charts where competitors require 10,000 or more, with models trained across more than 25 specialties. If accurate that materially shortens time to value and lowers the barrier for mid sized organizations, and it is the claim most worth validating against a reference customer. Vendor published figures are 96 to 98 percent accuracy, more than 1,000 charts processed per minute, up to 70 percent reduction in coding cost, 1.7 times coder productivity, denial reduction of up to 27 to 40 percent depending on the source, and measurable improvement within 30 days. The spread across the company's own materials is wide enough that these should be treated as marketing ranges rather than performance disclosure. Independent signal: CB Insights named RapidClaims an Outperformer in its automated and assisted coding ESP matrix, assessed against fifteen other companies including Oracle, Ambience and Suki. Funding is approximately 11.1 million dollars: an 8 million dollar Series A led by Accel with Together Fund participating, plus roughly 3 million dollars of previously unannounced seed led by Together Fund, with angel investors including Oscar Benavidez of Massachusetts General Hospital and Matthew Zubiller. Reported headcount is between 89 and 96 in mid 2026. Screened against the services filter and retained. The company markets coding outsourcing prominently, but independent profiling across PitchBook, Crunchbase, Tracxn and CB Insights describes a platform, the product line is software, and the outsourcing pages are demand generation rather than the business model. This is the opposite finding from MediCodio, which was rejected in the same sweep.

Solventum's Health Information Systems business is the incumbent that most of the clinical documentation market is competing against, and it is the largest deployment in this index by a wide margin: 1.4 billion dollars in annual sales, solutions in more than 30 countries, use by more than 75 percent of United States hospitals, and roughly 660 million clinical documents processed every month. The company was spun out of 3M in April 2024 and is listed as SOLV, based in Minnesota. This record covers the Health Information Systems segment only, which is led by Garri Garrison and rests on more than 40 years of medical coding expertise inherited from 3M. It includes M*Modal, acquired by 3M in 2019, and the 360 Encompass platform. The segment has three parts. Revenue cycle covers computer assisted physician documentation, direct to bill and coding automation, and clinical documentation integrity that identifies gaps in the patient story to improve quality metrics, risk adjustment and revenue capture. Performance management covers the classification and grouping methodologies that turn clinical information into the categories used to measure quality and determine payment. Speech and ambient covers speech recognition and ambient documentation, which captures audio of the clinician, the patient and any family members present and produces the visit document into the record system. On 5 August 2026 Solventum announced its intention to separate this business entirely, describing it as a scaled healthcare software company operating in a 10 billion dollar market growing 5 to 6 percent a year, and targeting completion within 12 to 18 months. Anyone evaluating this product is evaluating a business that expects to have different owners and different management inside two years. The company had already sold its purification and filtration business in September 2025.

Syllable answers the main line and the access centre for large health systems, across voice, text, chat and web. Its reference deployment is Houston Methodist, which put the system in front of every incoming call, answering and routing 100 percent of them before expanding into further use cases over time. The agents take scheduling calls in natural language and book, confirm, reschedule or cancel within the same conversation, writing directly into the source record or practice management system rather than leaving a task in a queue for someone to reconcile afterwards. Prebuilt connectors cover Epic, Oracle Health, MEDITECH and athenahealth, and the platform sits alongside existing contact centre telephony over standard telephony interconnect rather than replacing it, which matters for an enterprise that has already bought a contact centre platform. Scope extends past inbound scheduling into refills, frequently asked questions with context aware warm transfers, inbound and outbound referral scheduling, outstanding balance outreach, clinic level routing, and billing workflows including payment processing and automated balance verification through custom interfaces. Commercially it is the most legible product in this category. Independent 2026 comparisons report an enterprise rate of 3.60 dollars an hour and a trial tier at no cost, and describe the company's pricing page as documenting usage scenarios together with the third party pass through costs of speech recognition, speech synthesis and telephony, which those comparisons characterise as more transparent than its competitors. The same independent reviews note two cautions. Public buyer feedback is thin, so there is little peer review to draw on. And implementation effort is substantial, since escalation policy, routing logic and quality assurance have to be owned by the customer rather than delivered by the vendor.

Phreesia is the incumbent of patient intake. Founded around 2005 by chief executive Chaim Indig, listed on the New York Stock Exchange since 2019 and employing roughly 1,550 people, it reported 4,514 client organisations and more than 180 million patient visits enabled in 2025, both figures disclosed in securities filings rather than in marketing. The platform spans check in, appointment readiness, clinical and administrative data capture, consent, eligibility verification, time of service collection and patient payment, extended by the acquisition of the patient financing business AccessOne. It holds what independent analysis describes as the broadest record system connector library in its category, including an Epic listing, and publishes an unusually complete compliance position: HITRUST r2, SOC 2 Type 2 and PCI DSS Level 1. Artificial intelligence arrived recently and the company is candid that it is not the centre of the business. Phreesia VoiceAI, launched in September 2025, answers the practice telephone: refill requests with medication and pharmacy captured, balance enquiries and payments, medical records requests routed to the right team or release of information partner, clinical questions captured and triaged, and referral handling. Separately the company describes applying artificial intelligence internally to reduce reliance on manual and outsourced work, which it presents to investors as a source of margin expansion. Its chief executive has said publicly that artificial intelligence is a tool rather than the story. The third revenue line is the one a reader should understand. Network Solutions uses what the company calls the engagement window during intake to deliver messaging funded by life sciences companies, government bodies and advocacy organisations directly to patients. In March 2026 Phreesia reported its first year of positive net income and simultaneously cut fiscal 2027 revenue guidance to between 510 and 520 million dollars, citing reduced visibility into pharmaceutical spending; the shares fell sharply and securities class actions were filed in Delaware in May 2026 concerning that guidance. That is investor litigation about disclosure, not about the product.

Element5 automates the back office of post acute care: home health, hospice, skilled nursing and senior living. It is based in San Jose with a second headquarters in Chennai, was co founded around 2020 by chief executive Joe Randesi and chief revenue officer Eric Gordon among others, and has raised 48.5 million dollars, with both a 15 million dollar Series A in 2021 and a 30 million dollar Series B in 2022 led by Insight Partners. The origin is robotic process automation. The company's own early description was of trained robots that log into everyday systems and perform administrative tasks exactly as a person would, saving teams hours of repetitive clicks. That heritage matters when reading the current product, because another vendor in this index builds its whole architectural argument against precisely this approach, on the ground that recorded screen interactions break whenever a payer changes a portal. The platform has since moved toward agentic automation under the name Neos, described as a modular end to end solution spanning the patient financial journey, with eligibility and authorisation handled across a connected network. The workflow list is specific and long: insurance eligibility verification at admission and during episodes, authorisation processing including polling convenor portals for status changes, hospice benefit period verification, denial categorisation with prioritisation of high value cases, claims submission, cash posting, notice of admission and notice of election filing, physician order exchange, and the transition of assessment data into the federal reporting system. The company positions itself as a bridge between record systems, payers, convenors and clearinghouses, and offers building blocks so customers can deploy their own agents for unusual payer or local workflows. Distribution includes a partnership with Homecare Homebase, the post acute record system that states it serves around 37 percent of United States home health and hospice providers. Named customers in published case studies include VNA Health Group, VIA Health Partners, Vivie and Buckeye Home Health. The company was named to the CB Insights Digital Health 150.

Humata Health automates prior authorisation end to end, and its distinguishing claim is that the process can be made touchless: a clinician enters an order in the record system, and the platform determines whether authorisation is required, assembles the clinical documentation that supports it, and submits it, without further human involvement. In February 2026 Allegheny Health Network was named the first United States health system to run medical prior authorisation that way from order to approval. The company is based in Winter Park, Florida and was founded in 2023 by Jeremy Friese, a radiologist trained at Mayo Clinic and Harvard who is chairman and chief executive. He had earlier co founded Verata Health, which the health automation company Olive acquired in 2020, and served as a president of Olive; when Olive wound down, its remaining assets went to Waystar and to Humata. It raised 25 million dollars from a syndicate that is notable for who is in it: alongside Blue Venture Fund, LRVHealth and .406 Ventures sit Optum Ventures and Highmark Ventures, both arms of large payer organisations. The positioning is provider side and the company describes itself as built for yes, but it operates across the divide. It integrated the intelliPath technology of EviCore by Evernorth, a utilisation management business, so that provider clients reach a broad payer network. In June 2026 it launched what it describes as the first artificial intelligence enabled prior authorisation portal designed for providers rather than payers, extending beyond large health systems to independent practices, regional centres and specialty clinics. Its technology has also been made available within Microsoft Dragon Copilot. It sits inside the federal reform of this process as well. It joined the Centers for Medicare and Medicaid Services electronic prior authorisation acceleration initiative, and was selected as a technology partner for the WISeR model, standing for Wasteful and Inappropriate Service Reduction, which went live in January 2026 and applies artificial intelligence driven clinical review within Medicare. The company also supports an industry commitment to return more than 80 percent of prior authorisation decisions in real time by 2027.

HiLabs cleans healthcare data that other systems then rely on, and its centre of gravity is the provider directory. Founded in 2014 by chief executive Amit Garg and Neel Butala, based in Bethesda, Maryland, it employs around 340 people across four continents and has raised roughly 41 million dollars, including a 39 million dollar Series B in March 2024 led by Denali Growth Partners and Eight Roads Ventures with F-Prime Capital. The platform is MCheck, which ingests, cleans and enriches data for health insurers across provider data accuracy, clinical results, payment accuracy and value based care. The provider directory product validates and enriches more than 60 attributes per clinician, from phone numbers and specialties to whether a practice is accepting new patients, by cross checking signals across thousands of sources on a recurring cadence rather than through periodic one off cleanups. The company states the directory solution is live in most United States states and analyses data covering more than 80 percent of the country's healthcare providers, and it works with CAQH, whose provider data it combines with its own models. The evidence position is unusual for an administrative product. The company's method has been validated in peer reviewed research published in the Journal of the American Medical Association and referenced in a MedPAC report to Congress. The published work found that more than four in five physicians listed in health insurer directories had inconsistent entries, which bears directly on whether the provider directory provisions of the No Surprises Act are being met. The portfolio has since widened. MCheck NetworkIQ was deployed with a national behavioural health organisation serving millions of members. In August 2026 the company announced MCheck Intelligent Outreach, an agentic voice platform that calls providers to confirm and update their directory details, deployed by one of the ten largest United States health plans. Growth leadership includes president and chief growth officer Amir Desai and chief growth officer Robert Renzi.

Iodine Software reads every inpatient chart, continuously, and predicts where the clinical record and the documentation have come apart. Founded in 2010 in Austin, Texas, it won Best in KLAS for clinical documentation integrity in both 2022 and 2023. It is no longer independent. Waystar, the listed healthcare payments software company, completed its acquisition of Iodine on 1 October 2025 for a total of about 1.25 billion dollars, roughly half cash and half stock, buying it from shareholders led by the private equity firm Advent International. Waystar stated at closing that Iodine brought a client base of more than 1,000 hospitals and health systems and expanded its addressable market by over 15 percent. Iodine continues to trade under its own name as part of Waystar, which is why it holds a record here, and a buyer should understand they are contracting with a division of a listed payments company rather than a standalone vendor. The engine is called CognitiveML, and the company describes its approach as cognitive emulation: rather than applying rules to a chart, the models are built to mirror how a clinician reasons about a case. It draws on what the company states is one of the largest inpatient clinical datasets in the country, described as 1.5 billion medical concepts across millions of admissions, and now blends generative models and large language models with the earlier natural language processing and machine learning. The suite has widened well beyond documentation. Concurrent, launched in 2015, gave documentation teams real time visibility into charts. AwareCDI addresses documentation integrity across the middle of the revenue cycle. AwareUM, launched in February 2024, applies the same engine to utilisation management, prioritising cases for review and supporting medical necessity discussions with payers, and the company states it provides transparency and reasoning behind its predictions. AwarePre-Bill followed in May 2025, framed as right sizing reimbursement before a claim goes out. Two further companies were absorbed earlier and no longer trade independently: Artifact Health, a physician query platform, and ChartWise, a documentation integrity vendor. Reported results are financial rather than clinical. The company states its documentation suite helped hospitals recognise 1.5 billion dollars in additional appropriate reimbursement annually, and that in 2024 it helped health systems recover more than 2.1 billion dollars.

Machinify is the largest payment integrity organisation in the United States market and it exists as the result of four companies being combined under one private equity owner. Anyone searching for the constituent brands is looking at businesses that now sit inside this one. The sequence matters. In September 2024 New Mountain Capital merged The Rawlings Group, Apixio's Payment Integrity business and VARIS into a single platform. In early 2025 it acquired Machinify Inc, an artificial intelligence software company founded in 2016 in Palo Alto, and named the whole combined entity Machinify, with David Pierre as chief executive. In October 2025 the group acquired Performant Healthcare for a reported 670 million dollars, and through 2026 the Rawlings brand was retired into Machinify. Reported valuation at the time of the Machinify acquisition was around 5 billion dollars on revenue above 500 million. One split is worth recording precisely because it is the kind of detail that causes confusion. Only Apixio's payment integrity business went into this group. Apixio's Connected Care platform and value based care solutions were acquired separately by Datavant, so the Apixio name divided between two acquirers rather than moving as one. What the combined organisation sells to health plans spans subrogation, coordination of benefits, pharmacy payment integrity and complex claim review, delivered as what the company describes as a cloud based data intelligence platform for deploying purpose built artificial intelligence across the payment continuum, supported by clinical expertise and a large claims data asset. Company materials report service to more than 60 health plans, with some sources citing 75 to 85, including many of the twenty largest, alongside expansion into government programmes. An independent assessment worth noting alongside that: analyst trackers continue to place Cotiviti and Optum as the entrenched leaders in enterprise scale payment integrity, describing this company's market leadership as still emerging despite its scale.

Fathom is a San Francisco company selling autonomous medical coding: clinical documentation arrives from the record system after a visit, deep learning and large language models assign the codes, and complete results return for claim submission without a human coder touching most encounters. Chief executive Andrew Lockhart co founded it. Sources disagree on the founding year, giving 2015 and 2017. Coverage spans the full set of elements a coder assigns rather than a subset: diagnosis codes, procedure codes, evaluation and management levels, modifiers, provider assignment, units, shared services and documentation deficiencies, across specialties. Turnaround is stated at under two hours for a day's encounters, averaging 57 minutes. The published figures are unusually specific. Around 90 percent or more of encounters are coded autonomously or correctly flagged for documentation deficiency, accuracy is stated above 96 percent with ongoing audit programmes, and cost to code falls by 30 to 50 percent with a stated average of 42.3 percent. A customer, Your Health, reported a 95.5 percent automation rate at 98.3 percent accuracy across all service lines in March 2026. Two commitments distinguish it from the category. The company offers contractual service level agreements guaranteeing automation rate, accuracy and turnaround time, which converts published performance into an enforceable obligation. And it offers a risk free trial in which a provider validates coding quality on their own encounters before production models are switched on. Independent recognition includes a KLAS Spotlight report in September 2024 reporting 100 percent high customer satisfaction and validation of automation rates above 90 percent, and the top position for reducing the cost of care in the 2025 KLAS Emerging Solutions report. The company holds HITRUST i1 certification, obtained December 2024. It has raised roughly 61 million dollars from investors including Lightspeed Venture Partners, Alkeon Capital Management, Inflect Health, Tarsadia Investments and the Cedars-Sinai Accelerator, with a later strategic investment from CVS Health Ventures.

FinThrive is a healthcare revenue cycle management software company selling a broad suite to hospitals and health systems rather than a single product. Its stated scope covers patient access, charge and revenue integrity, claims and contract management, automation, analytics and education, and the company reports more than 4,100 customers including over half of United States hospitals and health organisations. The technical centre of the current strategy is FinThrive Fusion, described as a data intelligence platform built specifically for healthcare revenue operations, which unifies financial and payer data across the enterprise. On top of Fusion the company markets agentic artificial intelligence: autonomous agents that identify risk, orchestrate next best actions and execute work across the revenue cycle. At HIMSS 2026 it presented more than 50 artificial intelligence and automation use cases and positioned artificial intelligence as the operating model for revenue management rather than an added feature. Named products include Denials Prevention Manager, aimed at denials that are written off or missed entirely, and Community Advantage, a package for rural hospitals and community health systems under financial pressure. The company publishes an annual Transformative Trends survey of revenue cycle leaders, now in its third edition, whose 2026 findings included that more than 70 percent of respondents expect to reduce reliance on third party revenue cycle vendors and nearly 60 percent plan to consolidate vendors within three years, a trend the company's own consolidation pitch is built to serve. It was ranked by Black Book Research in three revenue cycle management categories in 2025. Its chief information security officer is Greg Surla. Founding year and headquarters were not confirmed in this pass and are left blank rather than guessed.

Medsender is a New York based healthcare workflow automation company whose product reads the documents and phone calls arriving at a medical practice and files what it finds into the electronic health record. It began in 2014 as a HIPAA compliant digital fax service and the automation layer came later, which is still visible in the product shape: fax transport, document editing, electronic signature and storage sit underneath, and the artificial intelligence is sold on top of them in named tiers. The platform has four parts. Fax automation reads each inbound fax, titles it, categorises it, tags it and uploads it to the correct patient chart, with new chart creation where none exists. Referral management classifies and routes inbound referrals into a dedicated workflow before a coordinator touches them, and reports status back to the referring provider. The AI Medical Assistant, branded MAIRA, answers inbound patient calls, schedules appointments, handles routine questions and produces recordings, transcripts and call summaries. A developer fax interface exposes the same extraction to other health technology companies through typed software development kits, webhooks and sandbox access. Integration is the strongest published surface for a company of this size. Named ambulatory electronic health record connections include athenahealth, eClinicalWorks, ModMed, NextGen, Practice Fusion and Ezderm, and an integration guide is published. The company raised a 5 million dollar Series A led by Ballast Point Ventures, announced January 2025, and is led by co chief executives Zain Qayyum, who founded it, and Salman Haque. Sources disagree on the founding year: company registries record 2014 while the founder dates it to 2015 in interviews. Extraction accuracy is claimed at 99 percent, but the figure appears as a customer testimonial in marketing copy rather than as a measured result, with no test set, denominator, document mix or independent validation. No model is named or described anywhere in public material.

Luma Health, founded in 2015 in San Francisco by Adnan Iqbal, Aditya Bansod and Tashfeen Ekram, sells what it now calls an operational artificial intelligence platform for health system patient access. The company states it works with more than 550 health systems, hospitals and clinic networks, has served more than 30 million patients, and integrates with more than 80 record and practice management systems. It raised 160 million dollars through a 130 million dollar Series C led by FTV Capital in November 2021, with Texas Medical Center and DocuSign Ventures among strategic investors. No later round was located. The artificial intelligence core is Spark, announced in 2024 and described as multi model and zero retention, and the company names the providers behind it, including models from OpenAI, Anthropic and Deepgram, fine tuned for healthcare. The patient facing voice product is Navigator, an agentic concierge that answers inbound calls in multiple languages, verifies a caller's identity, lists and confirms appointments, cancels directly in the record system and handles prescription refill requests. Its engineering lead describes the design plainly as several cooperating agents, each a model with a prompt and a set of tools, one verifying identity, another listing appointments, another cancelling. Alongside Navigator sit Fax Transform for inbound document processing, LumaPay for point of service payments, eligibility checking, self scheduling, waitlists and, from August 2026, Patient Pipeline, which converts advertising spend into booked appointments for organisations running Epic. The company reported deployment of artificial intelligence workflows at more than 50 health systems and more than 2 million hours of staff time saved during 2025, and says a 2026 release will extend the conversational agent to proactive outbound follow up driven by record data, visit notes and prescriptions. Integration is built in house rather than bought, spanning Oracle Health, Epic, eClinicalWorks, MEDITECH, athenahealth, NextGen and Greenway Health, with inaugural membership of the MEDITECH alliance programme and validated integration status with Oracle. Chief product and technology officer Marcelo Oliveira. Research and development centres in the United States, Brazil and Europe.

Weave, based in Lehi, Utah and listed on the New York Stock Exchange under the ticker WEAV, sells a patient communications, engagement and payments platform to small and medium healthcare practices, serving roughly 40,000 customer locations concentrated in dental and optometry with medical, veterinary and multi location enterprise practices alongside. The original business combined a practice telephone system with texting, digital forms, payment collection and review management, and the artificial intelligence has arrived on top of that distribution position rather than underneath it. In May 2026 the company launched an omnichannel AI Receptionist built with Google Cloud's Gemini Enterprise Agent Platform, which handles patient interactions across voice and text, preserves context so a patient starting on the phone and continuing by message never repeats themselves, routes conversations, and transitions to staff inside one workflow. A July 2026 release expanded that receptionist, added automated digital insurance capture and introduced stronger authentication for enterprise customers, with the company's own operating lead stating that larger customers are asking for more visibility into how the artificial intelligence performs. Authorised integrations with practice management systems drive scheduling, insurance eligibility verification and payment collection. Notably for this index, Weave names the model platform underneath its agent, which most vendors in this segment do not.

Flexbone builds artificial intelligence agents for the back office of outpatient healthcare, deliberately aimed at the organisations large vendors skip. Its strategic argument is stated plainly: the great majority of outpatient facilities do not run Epic or Cerner, the best funded competitors have built for Epic, and the rest of the market is left to systems nobody integrates with. Flexbone's answer is multi modal agents rather than interfaces. Voice agents answer and place calls for scheduling, triage, post operative follow up and payer follow up, navigating payer phone menus and holding on the line. Browser agents log into practice systems and payer portals the way a member of staff does, verifying eligibility across more than 25 portals and submitting prior authorisations where no interface exists. Document agents ingest denial letters, classify the cause against the encounter and republish corrected claims to clearinghouses. Voice Room, the product named on this list, plugs into an existing telephone system and analyses every call rather than the small sample manual quality review reaches, producing sentiment, compliance monitoring and automated scoring. Named system targets include Tebra and an ambulatory surgery centre platform. The company publishes entry pricing, begins engagements with a no cost operational audit, and embeds forward deployed engineers during implementation.

Drug and toxicology reference from Merative, the company formed in June 2022 when Francisco Partners acquired the Watson Health assets from IBM. Headquartered in Ann Arbor, Michigan; Merative chief executive Gerry McCarthy, with Sonika Mathur as general manager for Micromedex. Content is curated by clinical experts from primary literature with in line referencing and daily updates, and is used in more than 80 countries by providers, poison control centres, government departments, universities, pharmaceutical organisations and health plans. The artificial intelligence layer is search. Released 23 September 2025, it lets a clinician ask natural language questions about drug information including interactions and intravenous administration, and returns answers drawn from Micromedex content with a citation on every result that opens the underlying source in one click. Interface affordances include suggested searches and follow up prompts. The company describes the capability as clinically validated. Scoping note, because the boundary matters for this index. DynaMedex is a separate joint product combining this drug content with EBSCO's DynaMed disease content, and it is graded on the DynaMed record rather than here; a December 2025 agreement additionally routes Micromedex dosing and medication safety content into that product's generative layer. This record covers Micromedex itself. Two facts sit outside what a reference product normally carries and both are on the record. Micromedex is recognised as a drug compendium under United States federal law, which makes its content a determinant of coverage for certain off label uses rather than merely a guide to them. And in a separate arrangement the company has licensed a subset of its drug content into a consumer artificial intelligence answer engine as a premium source. Named number one for point of care drug reference in the 2026 Best in KLAS report, for the second time.

Synthpop is an API first, multi agent platform for healthcare administrative operations, not a clinical inbox tool. Its own description of the job is orchestration across the patient journey: referral and document intake, coverage and eligibility verification, prior authorisation, patient communication, and claims and denial follow up, delivered as one coordinated administrative layer rather than as separate point products. The hero workflow in its marketing is referral intake arriving as fax packets and the manual chasing of missing information that follows. Founded in 2023 by Elad Ferber, chief executive, who previously co founded Spry Health and led it to acquisition by ZOLL Itamar, and Jan Jannink PhD, chief technology officer, who co founded imeem and VoiceBase and teaches at Stanford. Headquartered in Cambridge, Massachusetts, previously Wellesley. A 15 million dollar Series A led by Ansa Capital was announced in February 2026, taking total funding to 23 million dollars, with Defy.vc, Peterson Ventures and Storm Ventures participating. The team behind FastStream and FastAgency, who contributed to Microsoft's AutoGen agent framework, joined the company shortly before that round. The company reports processing more than 2 million patients and integration with eight major EHR systems alongside billing and electronic prescribing platforms, and states that its system automates up to 80 percent of the business processes it handles. In April 2026 it was named the first healthcare focused partner agent in the Agent Gallery inside Google Cloud's Gemini Enterprise.

aiomics is a Berlin company building clinical data intelligence for European rehabilitation and acute care hospitals, founded by Sven Jungmann, a physician who describes watching paperwork erode time and purpose at the bedside. It raised a 2 million euro pre seed round in September 2025 led by Vorwerk Ventures with Calm/Storm, Norrsken Evolve and Rule30 participating. The product reads what a hospital already has, in whatever form it arrives. Speech, handwriting and existing documents, including PDFs, scanned letters and printed reports, are captured into a single validated workflow, structured, checked for completeness and consistency through a human in the loop process, and returned to existing systems as structured, coded, audit secure data with FHIR based handoff. From that structured record it drafts admission notes, discharge summaries, therapy briefings, insurer packets, rehabilitation applications and payer correspondence, all for physician review and approval, with interactive checklists ensuring packets are finished rather than left with gaps. The distinguishing feature is what it looks for rather than what it writes. aiomics surfaces contradictions, gaps and missing detail in the record itself, which is the failure mode this category is defined by and which almost every competitor treats as somebody else's problem. A physician on the company's own site puts it more sharply than any vendor copy does: for the first time someone understands how incomplete the records really are and does something about it, instead of copying the errors forward. Its compliance posture is built for Europe rather than adapted to it. All processing remains in the EU, infrastructure is C5 attested, information security is externally audited, and the company holds ISO/IEC 27001:2022 certification issued by TÜV NORD, while working toward ISO 13485 and Medical Device Regulation alignment and referencing the EU AI Act directly. Most notably for this index, the effectiveness of the product is currently under independent scientific evaluation at the Charité Institute for Medical Informatics, with results to be published on completion. The company states plainly that it believes in evidence over claims, for its own tools as much as for a hospital's records, and it caveats its own efficiency figures by noting that actual time savings depend on individual documentation.

Autonomize AI, founded in Austin in 2022 by Ganesh Padmanabhan and Kris Nair, sells a multi agent orchestration platform for healthcare knowledge work. It describes more than 160 pre built agents and copilots that turn unstructured material, clinical notes, PDFs, faxes and claims, into structured context for a reviewer to act on. The company raised a 28 million dollar Series A in 2025 and reports deployments at Fortune 100 healthcare organisations and top 20 pharmaceutical companies. The commercial centre of gravity is the health plan, which is why this record sits in revenue cycle and prior authorization rather than in clinical summarisation. The flagship is a Prior Authorization Copilot handling inpatient, imaging, cardiology, durable medical equipment and other service categories, designed to interface with a plan's existing medical management and medical policy systems rather than replace them. Around it sit copilots for payment integrity and pre payment review, medical versus pharmacy benefit determination, HEDIS care gap analysis, case management and clinical trial planning. It is cross listed into clinical summarisation because one of those agents is a genuine chart review product. The Medical Record Review Copilot aggregates multimodal charts from multiple sources and formats into a unified searchable view for chart reviewers to summarise and analyse, and it is distributed through the Microsoft marketplaces alongside the care gap copilot. Reported outcomes are efficiency figures rather than accuracy ones: care management teams spending 78 percent less time per case, an 85 percent improvement in case review efficiency, prior authorisation moving from twenty or thirty minutes to seconds, an 80 percent reduction in manual errors, and up to 55 percent savings in clinical and non clinical staff time on prior authorisation. All are vendor reported without stated baselines or methods. The company names real time governance, explainability and a human in the loop design in which clinical teams retain control as platform level differentiators.

Retrieve Medical Holdings, based in Bedminster, New Jersey, sells two clinician facing products built on the same engine, and since January 2026 a consumer facing third. Retrieve Dx, also marketed as Retrieve Dx/MDM, runs an intelligent search across a patient's record inside Epic, Cerner, Meditech or another EMR, reading labs, notes and imaging reports, and surfaces previous diagnoses, pre existing issues, comorbid and major comorbid conditions, abnormal results and potential risk factors to the physician for validation. PreviewMD, announced in 2025, applies the same technology to outpatient visit preparation, scanning up to a year of history over a customisable interval and producing a clinical note ready to drop into the EHR, formatted as a consult request or admission note, with optional health information exchange access for records held elsewhere. Retrieve Passport, in commercial production since January 2026, points the same extraction engine in the opposite direction. Rather than serving a hospital, it lets an individual pull their own longitudinal record out of a nationwide health information exchange into a consumer controlled account, with real time translation of summaries for care received abroad. Its signature artefact is a wallet sized card carrying a QR code that resolves to a concise medical summary a clinician can read in an emergency, with deeper record access released on the patient's explicit consent. A partnership with CLEAR announced in July 2026 supplies identity verification. This is a materially different regulatory proposition from the clinical products, and it is discussed on the HIPAA and stewardship axes. Two design properties are worth noting. Anything the software highlights can be opened in place to show the actual note or result in its original context inside the EMR, so a physician verifies against the source system rather than against the vendor's rendering. And the product writes back: once the physician decides an item is relevant, a single action pulls the underlying data and enters it into the chart in the correct format and location. Most products in this category read the record and stop; this one closes the loop. The company is chaired by Mark Rosenberg, a past president of the American College of Emergency Physicians, and is quoted over the counter as RMHI, which is recorded here under supplier continuity rather than as a comment on product quality. A buyer should understand what the product is optimised for. It is marketed as clinical documentation integrity, and the company states its case directly: surfacing additional comorbidities raises the Case Mix Index, that index directly affects reimbursement, and hospitals can anticipate increased revenue over time. It also reports a substantial reduction in physician queries, which is a genuine burden benefit rather than a revenue one. Both belong in the assessment.

Evidently, based in San Francisco, sells what it calls Clinical Data Intelligence: a layer that reads effectively everything in a patient's record, including labs, notes, imaging, scanned documents, faxes and outside records pulled through Care Everywhere and other exchanges, and turns it into summaries, drafts and answers inside the EHR. Three surfaces sit on that engine. AI Summaries produce a full chart summary on any clinical concept or a custom prompt. AI Drafts generate documentation in an editor. Ask Evidently is a conversational assistant embedded in the EHR that has already read the chart and will retrieve, summarise or draft on request, described by the company as a built in resident who has pre read everything. It is the broadest product in this category by care setting. Inpatient work covers admit notes, discharge summaries, clinical documentation improvement review and denial appeal drafting. Value based care covers HCC review and care gap reconciliation. Emergency medicine covers reading the chart on arrival, answering questions in medical decision making, note drafting and handoff. Perioperative covers pre operative review, transplant review, registry abstraction and patient safety and pediatric quality indicator review. Registry abstraction and safety indicator review are functions nothing else in this category performs. Named customers include University of Iowa Health Care, Allina Health and UNC Health, which selected Evidently in May 2026 for an enterprise deployment across its Triangle region hospitals and clinics. A study by KLAS Research found a 31.7 point increase in Net EHR Experience Score at University of Iowa Health Care after integrating the product, and Allina Health reports a 6x return through value based care risk adjustment and revenue capture. Unusually for this category, a long list of named clinicians at named institutions appear on the record by name and title rather than as anonymous quotes. One feature deserves specific attention before purchase. Because summaries can be generated from a user written custom prompt, and because the chat assistant answers open ended questions, the output surface is defined by the clinician at the point of use rather than by the vendor in advance. Whatever validation exists cannot cover a prompt the vendor never saw. That is a real and undisclosed shift of evaluation burden onto the buying organisation, and it is discussed on the autonomy axis.

Pieces is a physician led clinical AI company from Irving, Texas, founded by Ruben Amarasingham MD, who previously founded the Parkland Center for Clinical Innovation, one of the first applied clinical AI institutes embedded in a public health system, and directed biomedical informatics at UT Southwestern. Its cloud hosted Pieces Intelligence Platform condenses and summarises clinical data directly inside the EHR and pre generates progress notes, discharge summaries and multidisciplinary care plans for physicians, nurses and case managers. The company reports more than 10 million AI generated clinical documents produced to date and is backed by NIH funding. Current status matters here. Smarter Technologies acquired Pieces on 30 September 2025 and folded it into a new product, SmarterNotes, which combines the Pieces documentation workflows with SmarterDx clinical AI. Smarter Technologies was itself formed in May 2025 under New Mountain Capital from Access Healthcare, SmarterDx and Thoughtful.ai. The Pieces brand no longer has an independent web presence and piecestech.com now redirects to smartertech.com; the founder is now Chief Medical Officer of SmarterDx. Buyers should also note what the combination does to the product's purpose: SmarterNotes is marketed as producing notes optimised for reimbursement from the start, connecting admission to final payment, preventing queries and denials and identifying missed revenue opportunities. A summarisation tool has been fused to a revenue cycle engine, and that is a different product from the one Pieces sold alone. One attribution caution. The headline performance figures published alongside SmarterNotes, including 12 million cases analysed, a 5 to 1 return from day one and roughly 2.5 million dollars in annual net new revenue per 10,000 discharges, are attributed by the vendor to the SmarterDx offering, not to the Pieces summarisation product. Do not read them as evidence about the summariser. Pieces is also the subject of the first state enforcement action against a healthcare generative AI vendor in the United States, described in full on the governance and regulatory axes of this record. That matter was resolved without any monetary penalty, without any admission, and the company denies wrongdoing.

Clinical AI built for health plans rather than providers, which is what distinguishes it in this category. Where most indexed RCM vendors help providers get paid, Anterior automates the clinical review work inside payer organisations: prior authorization, risk adjustment, care management and payment integrity. Founded 2022 by Abdel Mahmoud, a physician, and Zahid Mahmood, with the premise drawn from observing that thousands of nurses and clinicians inside payer organisations are pulled away from patient care to perform administrative tasks that nonetheless require clinical judgement. The technical claim is a proprietary clinical reasoning architecture rather than general-purpose generative AI applied to medical text, which matters because the task is evaluating whether a specific patient's documented clinical picture meets a specific payer's medical necessity criteria, not summarising a chart. The company reports serving payer organisations covering over 50 million lives, 99.24 percent clinical accuracy, and a 76 percent increase in auto-approvals for customers. Funding totals roughly $63 to $64 million across three rounds, including a $20 million Series A led by NEA in 2024 and a $40 million round in February 2026, with investors including Sequoia Capital, NEA, FPV and Kinnevik. Context that makes this category consequential right now: sweeping federal prior authorization and interoperability requirements took effect from January 2026, mandating electronic submission and faster turnaround, which is driving payer investment in exactly this automation. That timing cuts both ways, and the index should say so. The same underlying capability that speeds legitimate approvals is the capability behind automated denials, and industry commentary in 2026 documents payers deploying machine learning to issue rapid denials on high-cost services. Anterior's reported metric is increased auto-approvals specifically, which is the favourable direction, but buyers and readers should understand that a clinical reasoning engine inside a payer is a utilization control system regardless of which direction it is tuned.

Autonomous medical coding engine that assigns ICD-10-CM/PCS and CPT codes from patient charts and routes encounters directly to billing with no human review. The technical approach is deliberately not end-to-end deep learning, and that distinction is the whole record: Nym uses proprietary Clinical Language Understanding built on computational linguistics, combining machine learning models with rules-based clinical ontologies that encode coding guidelines from the AMA, CMS and WHO. The engine reconstructs the clinical narrative of the encounter, then links ontological entities to codes, which is why it handles the failure mode that defeats keyword-based computer-assisted coding, most notably negation, where a note stating a patient does not have a condition must not generate that code. Reports over 95 percent accuracy, with encounters routed to billing when coding confidence exceeds that threshold and charts the engine cannot confidently code returned to human coders. Processes a reported 5.5 million or more charts annually across more than 250 US healthcare facilities, with named customers including Geisinger, Inova, Intermountain Health and OSU Physicians. Coverage began in emergency department and inpatient settings and expanded to outpatient in 2024, with multispecialty support including radiology. Built by an interdisciplinary team of physicians, computational linguists and engineers. The differentiator most worth checking is explainability: every assigned code carries an audit trail stating the logic for why it was assigned, which the company contrasts explicitly with black box AI. That is a substantive claim in a domain where incorrect codes create False Claims Act exposure for the billing organisation. Indexed alongside CodaMetrix, the closest comparator, which takes a different technical approach to the same problem.

Infinitus points voice artificial intelligence in the opposite direction from most of this index. Its agents do not answer patients calling a clinic. They call insurers and pharmacy benefit managers on a provider's behalf, navigate the automated menus, wait through the hold queues and hold a conversation with the representative who eventually answers. It is the specific administrative bottleneck almost no other vendor attacks directly. The work is the traffic standing between a prescription and a patient receiving it: verifying medical and pharmacy benefits, checking whether a treatment requires prior authorisation and whether one is on file, following up on appeals and formulary exceptions, checking claim status, retrieving explanation of benefit documents, and periodically reverifying eligibility for bridge programmes. Structured results are written back to the provider system rather than left in a call log. Two modes are offered: agents complete calls end to end, and a copilot called FastTrack initiates the call and hands a human staff member a live representative, skipping the menu system and the hold. Anything ambiguous routes to a human reviewer before finalisation. The distinguishing asset is a knowledge graph of payer specific behaviour assembled from millions of prior calls, so the agent knows which questions to ask each individual insurer rather than following a generic script. That is what makes automated payer calls tractable at all, given every payer runs a different phone tree and asks for different information. The company further states the graph lets an agent recognise when a representative gives incorrect information and push back in the conversation, correcting the error in real time. Founded in 2019 in San Francisco by Ankit Jain, chief executive and previously at Google, and Shyam Rajagopalan. Funding is reported inconsistently across sources and both accounts are recorded rather than reconciled: one gives roughly $103M across three rounds from investors including Andreessen Horowitz, ARCH Venture Partners, Atlas Venture, GV, Pfizer Venture Investments, RA Capital, SR One and Bill Gates, while another cites GV and Kleiner Perkins with a $51.5M Series C in October 2024. Scale is stated at more than 100 million minutes of healthcare conversation, over five million conversations and support for more than 125,000 providers, with the company claiming to power payer facing conversations for 44 percent of the Fortune 50. Reported performance includes calls completed faster than manual work with up to 10 percent greater data accuracy and a typical 50 percent return. The company states HIPAA and service organisation control attestations. The platform broadened considerably through 2025 and 2026: a Salesforce partnership announced in June 2025 allowing agents to be invoked from Health Cloud, Life Sciences Cloud and Agentforce, an agentic suite for health plan member services in February 2026, Infinitus Studio, a healthcare specific no code agent builder, in April 2026, and Lens, a conversation review engine covering both agent led and human led interactions, in May 2026, alongside a healthcare focused model context protocol server for agent interoperability. Positioned deliberately as a phone automation and agent layer inside the access stack rather than as an electronic prior authorisation network, a hub administrator or a case management platform.

Revenue cycle automation platform for medical groups and digital health companies, built around a single headline metric the company puts at the centre of its own product page: touchless claim rate, the percentage of claims submitted, processed and adjudicated correctly the first time with no manual intervention. The strategic framing is explicit and worth noting, because it distinguishes the company from most of the RCM category. Traditional RCM vendors aim to make manual cleanup work more efficient; Candid aims to prevent the cleanup by getting claims right on submission. The mechanism is a rules engine carrying reverse-engineered payer requirements that are continuously refined, combined with claim autocorrection that validates data pre-submission, with machine learning used to automate the feedback loop between claim insights and systemic rule changes. Customers can author and manage their own custom rules directly, with vendor training offered. The platform is API-first with flexible modern APIs for direct integration alongside out-of-the-box connections, and compiles provider rosters, credentialing data and custom key/value pairs to widen the share of the claims process that can be automated. Founded out of Y Combinator. Reported touchless claim rates and payor net collection rates above 95 percent, revenue growth of nearly 250 percent year over year in 2024, and a $52.5 million Series C led by Oak HC/FT in February 2025 bringing total funding to $99.5 million. Named customers include Talkiatry and Nourish. Holds a SOC 2 report covering security, availability and confidentiality.

Credentialing automation and provider network monitoring platform built around real time primary source verification across hundreds of sources, with continuous monitoring that flags expiring licenses, sanctions, and exclusion list changes. Distinguished by a Salesforce native architecture that lets organizations run credentialing inside their existing CRM rather than a separate system, and by offering both software and NCQA certified credentials verification organization services so customers can bring the function in house or outsource it.

Provider network operations platform automating credentialing, payer enrollment, state licensing, privileging, and ongoing compliance monitoring, positioned as an AI operations partner running a real time credentials verification organization. Integrates directly with primary sources including federation and federal databases to verify and monitor credentials, and pairs AI agents with credentialing specialists who review critical stages and handle exceptions. Serves health systems, digital health companies, payers, and provider groups.

Revenue cycle management platform built for dental service organizations, automating insurance claim follow up, explanation of benefits retrieval, payment posting, and accounts receivable analytics. Its InsideDial product uses AI to place payer phone calls and retrieve claim status, denial reasons, and payment details, auto generating verified records rather than leaving staff on hold. Combines AI with robotic process automation and syncs daily with practice management systems and payer portals.

Patient access platform embedding AI agents and unified patient context into healthcare contact centers, integrating bidirectionally with EHR and CCaaS systems so agents see live patient data and outcomes write back to the record. Covers scheduling, billing, referrals, nurse triage, pharmacy refill, transfer center, and operator console workflows, with AI agents handling inbound and outbound interactions alongside human staff. Founded 2005 and healthcare focused throughout, with a proprietary framework that extracts EHR decision logic as the platform's foundation.

Payer intelligence platform whose Smart Response engine analyzes hundreds of millions of claims transactions to learn payer specific rules and adapt to changing payment behavior, predicting claim line payment amounts and denial reasons in real time before submission. Three applications cover prediction, detection of emerging denial patterns, and recovery of unresolved denials. Distributed both directly and through a national health information network under a white labeled name.

Medication access and financial navigation platform that identifies financially at risk patients, matches them against a large network of financial assistance and manufacturer programs, and automates enrollment inside health system workflows using live EHR data. Combines a care team facing platform, a patient facing self serve experience, and a tech enabled service arm pairing automation with human navigators. Serves health systems, oncology practices, infusion centers, pharmacies, and life sciences companies.

Conversational AI platform whose agents handle inbound and outbound patient communication across voice, text, and web chat: answering calls, booking appointments, running new patient intake, answering insurance questions, taking refill requests, following up after visits, and handling recall and billing outreach. Built for multi location medical groups and outpatient specialty practices, integrating with EHR, practice management, and CRM systems. HIPAA compliant and SOC 2 Type 2 certified.

Dental AI platform that analyzes radiographs in real time, detecting and quantifying caries, periodontal bone loss, calculus, and other pathologies with visual overlays presented chairside. Founded by Harvard School of Dental Medicine and MIT alumni, the company holds multiple FDA clearances across detection and measurement claims and sells to dental groups and dental insurers, with a separate claims review product used on the payer side.

AI chart review platform that runs a pre bill review across every patient encounter rather than a retrospective sample, coding each visit from provider documentation, flagging missed revenue and compliance gaps while charts are still open, and either autocorrecting in the EHR or queueing problem charts for human review. Built on large language models with each implementation customized to replicate the reviews a client would ask a human reviewer to perform, in contrast to rules based NLP engines.

All in one cloud dental practice management platform covering charting, imaging, insurance, payments, and patient communication, now shipping a native AI layer under the Archy Intelligence banner. Archy Scribe generates clinical notes from inside the practice management system with access to the chart and treatment plan before recording begins, voice charting handles perio exams, and FDA cleared dental imaging AI is embedded through a third party partnership. Evaluate as a dental PMS adding AI rather than an AI native vendor.

Specialty specific cloud EHR and practice management vendor, formerly Modernizing Medicine, serving eleven medical specialties through its EMA and gGastro platforms. Its AI layer includes ModMed Scribe, an ambient documentation tool trained on de identified data sampled from a stated 750 million patient encounters, plus a set of AI assistants for scheduling, eligibility processing, prior authorization, and claim denial appeals. Evaluate as an EHR vendor adding AI rather than an AI native platform.

Hospital operations automation platform applying machine learning, generative AI, and behavioral science to predict operational bottlenecks and act on them inside the EHR. Three solution lines address inpatient capacity and discharge planning, perioperative care coordination, and surgical growth and operating room utilization. An AI Solution Factory lets health systems co develop custom operational assistants for additional workflows.

AI native medication access platform, formerly Tandem AI, that automates the path from prescription to patient: prior authorization generation and submission, appeals, pharmacy routing, benefits verification, and patient affordability programs. The platform is embedded at the point of prescribing in the EHR rather than activated after a claim is denied, and is offered free to providers and patients with monetization on the manufacturer and life sciences side.

AI patient billing and revenue cycle platform focused on the patient responsibility portion of provider revenue, which the company notes has risen from roughly 5 percent of provider revenue in 2010 to about 20 percent today and is projected toward 30 percent by decade end. Billie is the AI billing agent, engaging patients across chat, text, email, and voice to answer billing questions, explain what is owed, and take payment, with the company stating it handles the majority of cases and staff step in for exceptions. The platform covers intelligent statements, personalized outreach, payment plans, card on file, autopay, and refunds, plus an eligibility and benefits agent. Positioning is deliberately complementary rather than displacing: the company frames the EHR as the system of record and itself as the system of action on top of it. Integrated with more than 20 leading EHRs via API or FHIR, with a bidirectional Epic integration listed in Connection Hub on the Epic Showroom as of July 2026. Reported footprint is more than 3,000 healthcare facilities with over $1 billion in patient payments processed. Customer reported results include collections increases in the 75 to 300 percent range and average days to collect as low as 12.6. Holds HIPAA, SOC 2 Type 2, PCI DSS, and HITRUST i1 compliance. Backed by Sapphire Ventures and Y Combinator; CEO and co-founder Levon Brutyan.

AI orchestration platform for provider side revenue cycle, founded 2022 and built around the payer relationship rather than internal workflow alone. The company frames itself as an autonomous intelligence overlay rather than a replacement system of record, continuously monitoring aged accounts receivable, commercial denials, and shifting payer behaviour. Two product lines work together: Adonis Intelligence provides detection, alerting, denial clustering, smart worklists, and analytics, while AI Agents execute, navigating third party payer portals to run real time medical necessity and authorization checks, extracting unstructured clinical notes from the EHR to draft and file appeal letters, and progressing claims to resolution. Reported automation covers more than 70 percent of standard claim statusing and appeals tracking routines with a stated 20 to 30 percent reduction in long term revenue cycle operating spend. Available through the Epic Connection Hub. Mount Sinai Health System is a named customer using the platform to identify and prioritize billing exceptions, and Fox Valley Orthopedics reported recovering nearly $200,000 in denials. The company publishes an annual State of Revenue Cycle Management benchmark report, whose 2026 edition found payer denials and reimbursement pressure had overtaken staffing as the primary threat to revenue performance. More than $95 million raised including a $40 million Series C in March 2026; co-founder and CEO Akash Magoon.

Generative AI for the provider side revenue cycle, formerly Alpha Health. Unified Automation is the platform: a single engine spanning coding, clinical documentation integrity, prior authorization, and claims, designed to sit on top of existing EHR systems rather than replace them. The architectural argument worth understanding is how it differs from robotic process automation. Rather than recording and replaying screen interactions, which break whenever a payer updates a portal, the company trains models on the behaviour of payer portals, EHR interfaces, and clearinghouse connections so they tolerate interface changes. Modules include Coding Optimizer surfacing missed CPT and ICD-10 codes and compliance risks, CDI Optimizer flagging ambiguous diagnoses and missing specificity, Authorization Advisor handling prior authorization submission and payer specific requirement matching, Auth Status and Claim Status polling payer portals and writing results back to the EHR. The company describes an expert in the loop design that autonomously handles high confidence encounters and escalates edge cases to revenue cycle staff. Models are reported as trained on more than 43 million clinical documents. Reported footprint spans more than 650 hospitals and 6,500 outpatient facilities across all 50 states, with a strategic collaboration with Cleveland Clinic announced to launch revenue cycle AI tools. Customer reported results include a 13 percent reduction in accounts receivable days and 300 or more staff hours saved monthly. Headquartered in South San Francisco; more than $200 million raised.

Payment accuracy and integrity for health plans, and the oldest company in this index by founding date: it began in 1989 and its pre payment editing engine is the former ClaimsXten, with over 30 years of rules and policy content behind it. That history matters to the AI question, because the machine learning sits on top of an established rules engine rather than replacing it. Lyric42 is the orchestration platform, coordinating payment decisions across rules, workflows, policy, and payment accuracy products, and designed to let a plan run a multi vendor strategy through one integration to core systems. Replay is the audit automation engine, using AI to prioritize high impact claims and automate DRG validation, coordination of benefits review, and itemized bill analysis, with the company reporting up to 3x productivity and 4x findings for internal audit teams while reducing dependence on external vendors. LyricIQ provides the analytics layer. The stated framing is decision intelligence producing payment decisions that are independent, verified, and explainable, applied before disputes and rework enter the system. Named 2025 Best in KLAS for Pre payment Accuracy and Integrity, and reports serving more than 100 payers. Headquartered in Newtown Square, Pennsylvania.

Patient financial experience platform for hospitals, health systems, and physician groups, covering the part of revenue cycle the patient actually experiences: the bill. Cedar Intelligence is the AI decision engine personalizing billing journeys across channels, and Kora is the voice agent, launched April 2025 and developed with Twilio, trained on the company's proprietary billing data rather than a general model. Kora resolves common billing inquiries on first contact, explaining charges, identifying payment options, and connecting patients to financial assistance, with sentiment and tone detection, multiple language support including Spanish, and escalation to a live agent with full context when human judgment is required. One year in, the company reports Kora has handled nearly 400,000 patient calls across ten provider organizations spanning Epic and Cerner health systems, physician staffing groups, and large specialty groups, with Gastro Health alone accounting for more than 60,000 calls since September 2025. Kora Outbound extends the agent to proactive engagement of harder to reach patients. The company reports its platform data foundation exceeds one billion patient interactions. Its own published research is unusually pointed for a vendor: 40 percent of collectible dollars on its platform now come from uninsured patients, up 54 percent in three years, and it argues that billing experiences designed for financially stable patients are failing those under the greatest strain.

AI utilization management, and the only vendor in this index positioned to sit between payer and provider rather than serving one side. The Dragonfly platform (formerly CORTEX) uses real time predictive analytics to continuously assign an objective medical necessity score, the proprietary Care Level Score, and an anticipated level of care for every patient, with the stated intent of removing subjectivity from patient status determination so both parties work from the same evidence. Product lines cover Utilize for utilization review and case management, Navigate for discharge readiness and length of stay, Advise for physician advisor workflow and peer to peer escalation, and revenue integrity for denials and appeals. Precision UM is the deepest tier, a shared utilization management approach between a health system and a health plan built on common clinical data and historical determination patterns. Integration with the EMR is bidirectional. The company also sells Physician Advisor Services, supplementing night and weekend coverage or operating fully outsourced, so buyers should separate the platform from the staffed service. Named outcome: AnMed reported 14.6x return on investment over a twelve month period and 1,221 hours of front end review time saved through Precision UM with a national health plan. A third party study found Dragonfly rendered clinical review determinations 38 percent faster than fax and 15 percent faster than through the EMR. Headquartered in Franklin, Tennessee; co-founded by Joan Butters.

Prior authorization decision support for health plans and pharmacy benefit managers, the third payer side vendor in this index alongside Cohere Health and Alaffia, and the one weighted toward pharmacy benefit rather than medical. BanjoPA automates the end to end workflow: the CARE engine extracts information from faxed or digital prior authorization requests, validates and maps it to case fields, then matches the case against the payer's own clinical criteria. The distinguishing technical step is that CARE transforms dense clinical guidelines into decision trees, converting narrative coverage policy into an executable structure, and the platform reads prescriber notes directly from the EHR rather than relying on manual data entry or fax and phone follow up. The company states its model matches each request against the specific payer's rules rather than applying generic AI, and that every AI generated recommendation carries detailed evidence and an explanation. BanjoA&G extends the same approach to appeals and grievances. Positioned around CMS-0057-F interoperability and prior authorization compliance. Holds HITRUST r2 certification. Named implementation with Navitus, a large transparent pass through PBM owned by SSM Health and Costco serving over 18 million lives, expanded across employer and health plan lines including Medicare and Medicaid in December 2025. Founded by Saar Mahna.

Healthcare data and agentic artificial intelligence platform, described by the company as an agentic cloud for healthcare, built in three stages: data connectivity integrating major electronic health record systems with payer claims, pharmacy, laboratory, remote monitoring and social determinants sources; applications on top of that data; and autonomous agents on top of those. Gravity is the underlying data and intelligence platform, described as continuously trained on real world healthcare data including claims denials and edge cases, which the company argues gives each new agent institutional context at launch. Sara is the assistant line spanning insights, care management and clinical documentation through Sara Scribe. Named agent products now include Provider Copilot with pre visit summary and ambient scribing, an agentic access centre, and Flow Auth for prior authorisation automation. The product estate has widened considerably through five acquisitions. Humbi AI added actuarial intelligence, Cured added a healthcare native customer relationship platform, Pharmacy Quality Solutions added pharmacy quality, Story Health arrived in September 2025 bringing continuous specialty care delivered by live health coaches working alongside agents with remote biometric monitoring, and CaduceusHealth was acquired in May 2026, a revenue cycle management services provider whose United States based team serves nearly 4,000 providers and manages five billion dollars in gross patient charges annually. That last acquisition extended the Flow suite into full stack revenue cycle operations for ambulatory care. On the payer side, Galaxy is the risk adjustment and analytics platform, joined by a Galaxy utilisation management product for health plans. Independent validation is the strongest in this index and is current. In the 2026 Best in KLAS awards the company took the top score in three categories: Gravity at 93.2 for data analytics platform for providers against a market average of 83.9, Galaxy at 90.5 for data analytics platform for payers against an average of 87.2, and Cured at 90.1 for customer relationship management platforms, its third consecutive win in that category. Scores derive from validated interviews with customers rather than vendor submissions. Infrastructure partnerships are named rather than implied, spanning a multi year strategic collaboration with Amazon Web Services, validated partner status with Databricks, and a partnership with Snowflake. A joint centre of excellence with a services firm and an alliance in the United Arab Emirates announced in April 2026 extend delivery capacity and international reach. Customers include Kaiser Permanente, Ascension and Trinity Health, with six of the top 10 United States health systems reported, alongside Carina Health Network covering more than 1.5 million Coloradans, a five year engagement with Community Care of North Carolina, and a virtual heart failure programme with Allina Health Minneapolis Heart Institute. Founded 2014, headquartered in San Francisco, 675 million dollars raised including a 275 million dollar Series F, with Kaiser Permanente and Banner Health among investors while also being customers. Two things a reader should weigh. The Centers for Medicare and Medicaid Services accepted the company's application under Story Health Partners for the Advancing Chronic Care with Effective, Scalable Solutions model, positioning it to participate at the programme's July 2026 launch across both cardio kidney metabolic tracks. Taken together with a revenue cycle services acquisition and a coaching based care model, the company is moving from selling software to health systems toward operating care and delivering services with people. That is the shape this index screens out when it constitutes the whole business, and it does not here, because the platform remains licensable on its own terms. It is a direction worth watching rather than a finding. And no pricing of any kind was located.

Clinical intelligence platform sold to health plans, spanning utilization management, payment integrity, appeals, care management, and policy management. The company states it is sold to health plans, and that providers and manufacturers do not license the platform, which makes it payer side alongside Alaffia. Cohere Unify combines a reported 350 or more clinically trained AI models with workflow automation and human review to auto determine prior authorization requests in real time, and Cohere Connect provides the prior authorization APIs, reported to have carried more than 15 million submissions and to support 47 million payer provider interactions annually. The critical design fact is the direction of automation: the company reports up to 85 percent real time approvals and states explicitly that remaining submissions are reviewed by a clinician before final determination, meaning the model approves and humans decide the rest. Additional products include Cohere Review Assist for acute inpatient care, Cohere Policy Studio, and a Payment Integrity Suite extended through the September 2025 acquisition of ZignaAI. Reported outcomes include care access 70 percent faster than traditional processes, up to 9x return on investment, 94 percent provider satisfaction, and a provider NPS of 67. Named plan relationships include Humana and Geisinger. $90 million Series C in May 2025.

AI agent platform for healthcare operations, spanning patient access, revenue cycle, and care operations rather than a single workflow. Agents automate patient intake and registration, appointment scheduling, insurance eligibility verification, prior authorization, denial management, patient payment estimates, referral processing, and post visit follow up, each running a defined workflow end to end. Flow Builder is a no code interface that lets an organization's own IT and non technical staff build, train, and deploy agents, which places it alongside Bunkerhill and XCaliber as a build your own platform rather than a fixed product set. Integration is unusually pragmatic and is the stated differentiator: the company uses whichever method reaches the field, including APIs, RPA, and HL7, reading and writing structured and unstructured data across Epic, Oracle Health, MEDITECH, athenahealth, and payer portals. Named health system deployments include Intermountain, Trinity Health, and MUSC. Published customer results include a health system reaching 64 percent voice containment with roughly $360,000 annual savings, and an insurance FAQ voice assistant answering all inbound calls at a stated $4 saving per call. Backed by Greylock and ICONIQ Growth.

Multi agent platform automating clinical and administrative workflows from a single interface, with a coordinated network of role specific agents: an AI Receptionist handling inbound and outbound calls, scheduling, and patient communication; an AI Medical Assistant running intake, triage, and history capture; an AI Scribe producing real time documentation with ICD-10 and CPT evidence links; AI Coder and Biller agents for coding and revenue cycle; and an AI Inbox Manager working refills, messages, labs, and follow ups. States bidirectional integration with Epic, Cerner, and Allscripts and HIPAA compliance, with paperless intake syncing to the EHR. Marketed on reduced clinical support staff cost and shorter patient wait times, with stated attention to rural and underserved providers. Founded 2023 in Bellevue, Washington; emerged from stealth in late 2025 with a seed round. Early stage, and the breadth of the agent roster should be weighed against how recently the company began selling.

Hub of conversational AI agents for hospitals, operating across three orchestrated layers: triggers, where agents identify clinical gaps and risks from health assessments, prescriptions, and diagnostic findings; navigation, where agents qualify patients and guide care journeys; and revenue, where pending care is converted into booked services. Patients calling or messaging reach conversational AI with no menu and no IVR, and the agent accesses the real schedule to resolve the request end to end. After a visit an agent reads the medical record, identifies prescribed exams and consultations that were never booked, and proactively offers scheduling over WhatsApp, recapturing care that would otherwise be lost to follow up. Other agents confirm appointments with preparation guidance to reduce no shows. WhatsApp as the primary channel reflects the market: the company serves hospitals in Brazil and Mexico and is scaling across Latin America, which makes it one of the few vendors in this index built for a non US care and communication context. Stated customers include Dasa, the largest diagnostics network in Latin America, and Rede D'Or, the largest private hospital chain in Brazil, alongside a public health system deployment in Sao Paulo, with reach stated at more than five million lives. Founded by physician Joao Vitor Innecco, who has said the company was prompted by his grandmother's late breast cancer diagnosis. Raised a R$8 million pre seed round led by Afya with angel participation from figures associated with Sirio Libanes and Amil, and is supported by the Mayo Clinic accelerator and NVIDIA Inception while preparing a United States expansion.

Agentic patient services platform for pharmaceutical manufacturers, automating the post prescription access journey that determines whether a prescribed therapy ever reaches the patient. Named agents handle distinct functions: a consent agent manages opt in for sharing patient health information across manufacturers, specialty pharmacies, and provider hubs; a marketing agent personalizes educational outreach from multi source data; and an enrollment agent accelerates virtual hub enrollment by automating document verification, form completion, and payer navigation around the clock. Ships modular pre configured solutions including automated annual reverification, digital enrollment, bridge to copay sweeps, and click to agent conversational interfaces. The company positions itself as an alternative to traditional labor intensive hub models, where enrollment and reverification are handled by large human teams. Formerly Lifelink Systems, founded 2015; Precision AQ made a strategic investment in 2025 and named an incoming chief executive.

AI native revenue operations platform for post acute care providers including home health, hospice, home care, and nursing homes, a segment the larger revenue cycle vendors largely do not serve. Automates the referral to reimbursement cycle across revenue assurance, smart intake, authorization autopilot, billing operations, and platform intelligence. The model identifies upstream data, documentation, and coverage risk inside the EMR to prevent denials before submission, centralizes and auto extracts referrals arriving by fax, email, and portal, automates prior authorizations from submission through renewal, and resolves claims to cash through posting, reconciliation, and prioritized denial follow up. Routine work is automated while exceptions surface to human billers who make the decisions. Voice agents for insurer information requests are in development. Founded 2025 by Kevin Calcado and JJ Ram; $4.4 million seed in January 2026 led by Maverick Ventures with Peak XV, Y Combinator, and executives at large post acute providers participating.

AI revenue integrity platform for specialty physician practices, surgery centers, and health systems, working both sides of the denial problem. To prevent denials it reviews every encounter against coding standards, payer policy, and the practice's own contracts, checking CPT, ICD-10, HCPCS, modifiers, NCCI edits, and documentation completeness, returning suggested corrections that carry the underlying rule and its source from CMS, NCCI, or payer policy rather than an unexplained flag. To recover them it identifies root cause, retrieves records, references payer policy and contract terms, drafts the appeal packet with clinical evidence, and tracks it through adjudication. Also provides ambient scribing across dozens of specialties, benchmarks payer rates to surface underpayments, and tracks payer policy changes. Runs on US based cloud infrastructure stated as HIPAA and SOC 2 compliant. Reports 55 to 57 percent fewer denials and 98 percent coding accuracy for customers. Co founded by a former healthcare AI product manager at Google and a CTO with explainable AI research background at MIT CSAIL; $4.3 million seed in November 2025 led by Nexus Venture Partners with Y Combinator.

AI native operating system for behavioral health clinics, combining a set of named AI workers with an integrated EHR, CRM, and revenue cycle management in one platform. Sarah, the admissions coordinator, answers inbound calls, texts, and faxes around the clock and verifies insurance in real time, with more than 100,000 patients booked reported. Emma, the clinical assistant, generates ICD-10 and CPT coded session notes within about 30 seconds and is reported to have supported more than 3 million patient sessions. Eric handles coding, claim scrubbing, submission, and denial management. Laura manages between visit engagement. The fully integrated platform launched April 2026, partners with athenahealth through the athenaOne Marketplace, and reports clinics booking 30 percent more patients with clinicians saving more than two hours daily, across hundreds of mid to large behavioral health clinics. Behavioral health operations are a distinct problem from general practice, and the specialization is the point. Backed by Y Combinator, Precursor Ventures, Pioneer Fund, Rebel Fund, and Expansion Venture Capital.

Agentic AI for health plan claims operations, and the only payer side vendor in this lane: the buyer is the plan rather than the provider. Covers the full claims lifecycle across payment integrity, utilization management, and appeals. Proprietary optical character recognition digitizes unstructured itemized bills and medical records, agents extract and structure clinical facts and cross reference a claim against the complete patient record, clinical criteria, and policy guidelines, automating routine cases and prioritizing high value claims for human review. A generative assistant helps reviewers summarize records, source guidelines, and draft determination responses. The company states it deliberately avoids black box denial algorithms: every recommendation carries a clinical rationale and traceable citations, and licensed clinicians validate and sign off. Maintains SOC 2 Type II, HIPAA, and HITRUST. Reports saving health plans more than $120 million, over 20 percent average savings on high cost facility claims, and go live in roughly 30 days. Founded 2020 by siblings TJ Ademiluyi and Adun Akanni; $55 million Series B in February 2026 led by Transformation Capital, bringing total funding above $73 million.

AI billing and revenue cycle management for dental practices, combining automation with in house billing staff. Connects directly to practice management systems including Open Dental, automating insurance verification with full benefit breakdowns, clean claim submission with attachments, payment posting within 24 hours, denial appeals using payer specific templates, and accounts receivable follow up tracking claims aging past 30, 60, and 90 days. The distinctive capability is an AI voice agent that calls payers directly when a resubmitted claim shows no update, navigating the phone tree and updating claim status automatically, the same payer facing pattern Prosper AI applies on the medical side. The vendor reports maintaining current contract data across more than 50 major payers, enabling automated eligibility without manual contract uploads. Founded 2023 by Shreyas Parab and Anton Lin; seed stage with AI Grant among investors.

Agentic operating system positioned as a coordination layer across the systems a provider already runs rather than a replacement for them, on the premise that health systems accumulated EHRs, billing platforms, and scheduling tools over two decades without ever acquiring a layer to coordinate between them. Merlin is the role based agent line, and Patient Navigator, the first shipped agent, spans scheduling, prescription refills, outreach, intake, referrals, prior authorization, and billing resolution. The architecture is deliberately semi autonomous: agents run routine administrative workflows end to end and act across silos in real time, while a human in the loop structure keeps teams in control of critical decisions, with the degree of autonomy varying by whether a task is operational or clinical. The platform blends generative AI with traditional machine learning and microservices so deterministic tasks stay deterministic. Reports processing more than 8 million chart updates and generating over 160,000 EHR updates daily across more than 700,000 unique patients, with the navigator agent saving providers an average of six hours of manual work per day on refills alone. EHR integrations include Epic, Cerner, athenahealth, and eClinicalWorks, with listings on the athenahealth and AVIA marketplaces. Led by co founder and CEO Prakash Khot, previously a co founder of Skyflow; $6.5 million seed announced May 2026. Headquarters is reported as Andover, Massachusetts in funding announcements and as Plano, Texas by Crunchbase; this record does not resolve the discrepancy.

Indexed for the AltitudeAI product suite rather than for the underlying revenue cycle platform, which is treated as context under this index's product scoping rule. AltitudeAI, launched January 2025, brings the company's AI capabilities under one brand across a cloud based RCM platform serving a reported one million providers and processing more than six billion transactions annually, reaching roughly half of US patients. AltitudeCreate applies generative AI to autonomously draft appeal letters for denied claims, drawing on a library of more than 1,100 payer specific appeal templates. AltitudePredict uses predictive analytics to score and prioritize denied claims by expected cash value and likelihood of being overturned. AltitudeAssist, in Claim Manager, converts user prompts into automated denial prevention recommendations that fix issues before submission, which the company reports compresses a three day process to roughly three minutes. The company reports early AltitudeAI results of appeal package creation three times faster, saving about 16 minutes per package. Publicly traded (NASDAQ: WAY). On 1 October 2025 Waystar completed its acquisition of Iodine Software for a total of about 1.25 billion dollars, roughly half cash and half stock, from shareholders led by the private equity firm Advent International. Iodine brought clinical documentation integrity, utilisation management and pre bill review to a company whose own assets were financial, and Waystar described the combination as uniting one of the largest financial datasets in the industry with one of the largest clinical ones. It stated the deal added more than 1,000 hospitals and health systems and expanded its addressable market by over 15 percent. Iodine continues to trade under its own name and holds a separate record in this index; this record remains scoped to AltitudeAI.

Indexed for the AI products embedded in Elation's primary care platform, not for the electronic health record itself, which is treated as context under this index's product scoping rule. Note Assist is an ambient scribe that transcribes the visit and structures it into the clinician's own note templates natively inside the chart rather than as a bolt on. Actions listens for clinical intent within the note and drafts the resulting work, including prescriptions, lab orders, and referrals. Clinical Insights surfaces conditions, labs, and medications as a contextual summary at the point of care. AI Fast Lane, launched March 2026, applies Smart Coding to suggest diagnosis and procedure codes from the visit note and problem list, routing claims above a confidence threshold straight to submission without manual review. The commercially material fact for buyers is that Elation states its native AI is included at no additional cost with the EHR subscription. The company was named top solution for Small Practice Ambulatory EMR/PM for 1 to 10 physicians in 2026 Best in KLAS, a recognition covering the platform rather than the AI. Founded 2010 by Kyna Fong and her brother.

Enterprise ambient AI documentation platform that turns the clinician patient conversation into a structured, billable note inside the EHR. Named Best in KLAS for Ambient AI in both 2025 and 2026, and reported in use at more than 250 health systems including Kaiser Permanente across roughly 25,000 physicians, Mayo Clinic, Johns Hopkins, Duke Health, UPMC, and the VA. The defining technical strength is Epic depth: embedded across Haiku, Canto, and Hyperdrive with bidirectional note sync, plus an athenahealth partnership, covering more than 28 languages and 55+ specialties across outpatient, inpatient, and emergency settings. Linked Evidence maps every part of a generated note back to the source audio so a clinician can verify any sentence against what was actually said before signing. The platform has extended into structured orders, coding context for revenue cycle, and real time prior authorization through a collaboration with Highmark Health and Allegheny Health Network. Founded 2018 by Shiv Rao, a practicing cardiologist, and Zachary Lipton of Carnegie Mellon.

AI documentation suite pairing an ambient scribe with point of care automation modules, positioned as an operating system rather than a note taker. AutoScribe produces a fully structured note in about twenty seconds, classifying statements into documentation sections with specialty tuned models covering more than 200 specialties including emergency and hospital medicine. The surrounding suite is what distinguishes it: AutoCDI validates notes against ICD-10 and CPT requirements at the point of care with audit trails for revenue cycle teams, AutoAVS generates patient friendly after visit summaries in the patient's language, AutoRefer drafts referral letters, and AutoPrep reads prior charts to prepare a visit agenda. A Chart Awareness platform launched February 2026 grounds notes in the full longitudinal record including prior notes, labs, imaging, medications, and problem lists. Native API integrations with Epic, Oracle Health, and athenahealth. Cleveland Clinic selected Ambience over four rival scribes for a five year deployment; also reported at UCSF, Memorial Hermann, John Muir Health, The Oncology Institute, and GI Alliance. Support is English first, which points the product at large health systems rather than independent practices.

AI voice agents for patient access and revenue cycle telephony. The distinguishing capability is direction: alongside patient facing calls for scheduling, intake, and billing questions, the agents call payers directly, navigating IVR trees, waiting on hold, and speaking with representatives to obtain benefits and prior authorization details when electronic eligibility transactions return incomplete data, then writing structured results back to the EHR or practice management system. Every call is automatically reviewed by AI for accuracy and compliance rather than by manual audit. The vendor reports reaching more than 150,000 healthcare providers and cites roughly three week implementation. Founded 2023; raised a $30 million Series A led by Andreessen Horowitz in 2026, following a $5 million seed.

AI platform for inbound healthcare document and referral operations. RaeLM, the company's proprietary vision language model, reads unstructured inbound material including faxes, scanned forms, and handwritten documents, extracts the clinical and administrative data, and evaluates it against payer criteria to flag likely denials before submission. The vendor reports RaeLM was trained on more than 100 million anonymized healthcare documents, 2.3 billion data fields, and 8,000 sets of payer criteria, and that the platform processes more than 10 million documents a month for over 150 healthcare organizations. Tennr Network gives referring providers, receiving providers, and patients shared referral status visibility. Voice AI for referral phone workflows was added in 2026. Raised $162 million total, including a $101 million Series C led by IVP in June 2025 at a $605 million valuation.

No code AI workflow automation for pharmacy and healthcare operations, with a center of gravity in 340B program compliance. The platform screens 340B eligible claims, uses language models to investigate unstructured EHR data for referral based savings, and automates rebate reporting, Maximum Fair Price reconciliation, intake, and prior authorization. Referral Agent, launched June 2026, is positioned by the company as the first AI agent purpose built for 340B referral capture. The vendor reports customers including Tampa General Hospital, Renown Health, and Salinas Valley Health, more than 100 healthcare organizations on the platform, and customer reported reductions in manual work of up to 97 percent. Founded by Joy Liu, previously an operator at a health system specialty pharmacy company. Raised a $50 million Series B in 2025.

Agentic AI platform for health systems. Carebricks lets clinical and operational teams build, deploy, and govern their own AI agents across clinical, operational, and administrative workflows rather than buying a point solution per use case. Agents in production include coronary calcium detection on routine chest CT, nephrology triage, lung nodule follow up, referral prioritization, prior authorization packet assembly, and registry automation. The company develops its own FDA cleared imaging algorithms that run inside the platform, including algorithms for coronary artery calcium and aortic valve calcium on contrast enhanced non gated chest CT, mitral annular calcification, and bone mineral density. CMS established a national billing code and OPPS payment for algorithmic CAC and AVC analysis on chest CT effective April 1, 2026. In production at Cleveland Clinic, the University of Texas Medical Branch, Intermountain Health, and Mayo Clinic. Founded by Nishith Khandwala, previously a researcher at Stanford's Center for Artificial Intelligence in Medicine and Imaging.

Precision medicine company (NASDAQ: TEM) whose provider software is what this index covers: Next, an AI clinical decision support system that alerts clinicians to patients who may have fallen off care guidelines, backed by a vendor reported 662 patient prospective study across six sites; Hub, a physician platform rebuilt on an agentic architecture including a prior authorization agent; and David, a generative AI clinical assistant deployed directly into the EHR, with Northwestern Medicine as the first health system. Tempus acquired Deep 6 AI in March 2025, adding a precision research platform that applies natural language processing to structured and unstructured EMR data to match patients to clinical trials in near real time and to generate real world evidence. Deep 6 reports real time EMR feeds across more than 30 health systems, an ecosystem of over 1,000 research facilities including 18 academic medical centers and 11 NCI designated cancer centers, and that sites find more than 25 percent more patients than with traditional recruitment; the company notes 92 percent of trial inclusion and exclusion criteria benefit from unstructured data and that 15 to 20 percent of eligible patients are found through unstructured data alone. Outputs are positioned as decision support requiring trial team validation before action. The sequencing and pharma services businesses are context, not indexed products.

General Catalyst backed roll up of Athelas, Augmedix, and Memora Health selling ambient clinical documentation that flows directly into autonomous coding, clinical documentation integrity, and claims automation. The ambient line spans Augmedix Go (AI drafted notes), Assist (AI plus specialist review), and Live (synchronous human documentation), integrates with more than 50 EHRs including Epic, Oracle Health, and MEDITECH, and is reported to power more than 250,000 providers. A January 2025 Vizient contract provides negotiated access for member health systems.